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SCIENTIFIC OPINION 
Scientific Opinion on the maintenance of the list of QPS biological agents 
intentionally added to food and feed (2013 update)
1
 
EFSA Panel on Biological Hazards (BIOHAZ)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
EFSA is requested to assess the safety of a broad range of biological agents in the context of notifications for 
market authorisation as sources of food and feed additives, enzymes and plant protection products. The qualified 
presumption of safety (QPS) assessment was developed to provide a harmonised generic pre-assessment to 
support safety risk assessments performed by EFSA’s scientific Panels. The safety of unambiguously defined 
biological agents (at the highest taxonomic unit appropriate for the purpose for which an application is intended), 
and the completeness of the body of knowledge are assessed. Identified safety concerns for a taxonomic unit are, 
where possible and reasonable in number, reflected as ‘qualifications’ in connection with a recommendation for a 
QPS status. The list of QPS recommended biological agents is reviewed and updated periodically. Therefore, the 
only valid list is the one in the most recently published scientific opinion. The 2013 update reviews previously 
assessed microorganisms including bacteria, yeasts, filamentous fungi, oomycetes and viruses used for plant 
protection purposes. All taxonomic units previously recommended for the QPS list had their status reconfirmed. 
The new notifications since the last QPS update were reviewed. Gluconobacter oxydans and Alphaflexiviridae 
were assessed for the first time and were recommended for the QPS list. The information of the previous opinion 
was updated for the taxonomic units on the QPS list. Qualifications for the taxonomic units included in the QPS 
recommended list were reviewed and confirmed. Filamentous fungi and enterococci were not recommended for 
the QPS list following updating and reviewing of current scientific knowledge.  
© European Food Safety Authority, 2013 
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SUMMARY 
The European Food Safety Authority (EFSA) asked the Panel on Biological Hazards (BIOHAZ) to 
deliver a Scientific Opinion on the maintenance of the list of QPS biological agents intentionally 
added to food or feed (2013 update). The question included four specific tasks in the terms of 
reference (ToR).  
The first required a preparation of an update of the list of biological agents for intentional use in feed 
and/or food, or as sources of food and feed additives or enzymes and as plant protection products for 
safety assessment as notified to EFSA Units and/or Scientific Panels such as Pesticides, the Panels on 
Additives and Products or Substances used in Animal Feed (FEEDAP) and Genetically Modified 
Organisms (GMO). The list was updated with the notifications received where applicable by EFSA 
Panels and Units since the last review.  
The second ToR was concerned with an annual review of the list of biological agents recommended 
for the QPS list. Where appropriate new taxonomic units should be assessed for their suitability for an 
inclusion in the QPS list, and taxonomic units previously assessed should be reviewed where new 
information has become available. The information provided in the previous opinion should be 
updated where appropriate. The BIOHAZ Panel confirmed all taxonomic units previously 
recommended for the QPS list following review. The notifications were assessed. Gluconobacter 
oxydans and Alphaflexiviridae were assessed for the first time and recommended for the QPS list. The 
information of the previous opinion was updated for the taxonomic units on the QPS list. 
The third ToR required a review of the qualifications for taxonomic units included in the QPS 
recommended list and in particular the qualification regarding antimicrobial resistance in taxonomic 
units recommended for the QPS list. The information of the previous opinion was updated and the 
qualifications were confirmed.  
The fourth ToR concerned a review and update of the body of knowledge for notified filamentous 
fungi and enterococci. The knowledge of filamentous fungi notified to EFSA was updated. Although 
numerous data, published since the 2012 QPS opinion, have contributed to partially fulfil gaps of 
knowledge, too many unknowns remain in 2013 to allow a filamentous fungus to be recommended for 
the QPS list.  
Enterococcus faecium is not recommended for the QPS list in spite of the recent scientific knowledge 
allowing a differentiation of pathogenic from non-pathogenic strains. This is of value for the 
FEEDAP Scientific Panel dealing with the strain specific notification, but it is too recent knowledge 
for a QPS recommendation, considering the recent information on the evolution of the epidemiology 
of Enterococcus infections in human.  
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BACKGROUND AS PROVIDED BY EFSA 
A wide variety of bacterial and fungal species are used in food and feed production, either directly or 
as a source of additives or food enzymes. Some of these have a long history of apparent safe use, 
while others are less well understood and may represent a risk for consumers. The Scientific 
Committee reviewed the range and numbers of microorganisms likely to be the subject of an EFSA 
Opinion and published a list of microorganisms recommended for Qualified Presumption of Safety 
(QPS)
4,5
. 
The Scientific Committee recommended that a QPS approach should be implemented across EFSA 
and applied equally to all safety considerations of microorganisms that EFSA is required to assess. In 
its conclusion on the value of QPS as an assessment tool, the Scientific Committee recognised that 
there would have to be continuing provision for reviewing and modifying the list of organism given 
QPS recommendation. They recommended that the EFSA via its Panel on Biological Hazards 
(BIOHAZ) should take prime responsibility for this and should review the existing QPS list and any 
additions at least annually. Reviews may occur more frequently as necessary but there should be a 
formal requirement that even when no changes are proposed, a statement should be made annually 
that QPS recommendation is being maintained for the published list. 
The benefits of the introduction of QPS would be a more transparent and consistent approach across 
the EFSA units and/or Scientific Panels (such as Pesticides, FEEDAP, GMO) and the potential to 
make better use of resources by focussing on those organisms, which presented the greatest risks or 
uncertainties.  
In the first annual QPS review and update
6
, the existing list of QPS microorganisms was reviewed and 
EFSA’s initial experience in applying the QPS approach was described. In addition, following the 
identification of antimicrobial resistance as a universal qualification of safety in the previous 
Opinions on QPS, the issue was addressed in line with the opinion developed by the BIOHAZ Panel
7
 
on ‘Foodborne antimicrobial resistance as a biological hazard’, and related documents8,9 of other 
EFSA Panels.  
The potential application of the QPS approach to microbial plant protection products was discussed in 
the 2009 review
10
. In 2009, viruses were assessed for the first time. Insect viruses (Baculovirideae) 
and in the case of zucchini yellow mosaic viruses the Potyvirideae family as the highest possible 
taxonomic unit were added to the QPS list. Bacteriophages were considered as not appropriate for the 
QPS list. A potential presence of antimycotic resistance of yeasts referred to on the QPS list was 
considered. It was concluded that yeast strains resistant to antimycotics used for treatment of 
infections in humans might be of public health concern.  
In the last QPS update in 2012
11
 the previously assessed microorganisms including bacteria, yeasts, 
filamentous fungi and viruses used for plant protection purposes were reviewed and the QPS 
                                                     
 
4  See www.efsa.europa.eu/en/science/sc_commitee/sc_opinions/972.html 
5 See http://www.efsa.europa.eu/en/scdocs/scdoc/587.htm 
6  Opinion of the Scientific Panel on Biological Hazards on a request from EFSA on the maintenance of the list of QPS 
microorganisms intentionally added to food or feed. The EFSA Journal (2008) 923, 1-48 
7  Opinion of the Scientific Panel on Biological Hazards on a request from EFSA on foodborne antimicrobial resistance as 
a biological hazard. The EFSA Journal (2008) 765, 1-87 
8  Guidance on the risk assessment of genetically modified microorganisms and their food and feed products. EFSA Journal 
2011;9(6)2193, 54pp. http://www.efsa.europa.eu/en/efsajournal/pub/2193.htm 
9  Guidance prepared by the Scientific Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) on 
the assessment of bacterial susceptibility to antimicrobials of human or veterinary importance. EFSA Journal 
2012;10(6):2740, 10 pp. doi:10.2903/j.efsa.2012.2740 
10  Scientific Opinion of the Panel on Biological Hazards (BIOHAZ) on the maintenance of the list of QPS microorganisms 
intentionally added to food or feed (2009 update). EFSA Journal 2009; 7(12)1431, 92 pp. doi:10.2903/j.efsa.2009.1431 
11  Scientific Opinion of the Panel on Biological Hazards (BIOHAZ) on the maintenance of the list of QPS biological agents 
intentionally added to food and feed (2012 update). EFSA Journal 2012;10(12):3020, 84 pp. 
doi:10.2903/j.efsa.2012.3020 
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recommendations of the previous years were confirmed. Qualifications, intended to exclude potential 
safety concerns, relating to the agents recommended for the QPS list were also reviewed, clarified and 
updated where necessary. Specific sections dealing with antibiotic resistance relevant for the 
qualification of QPS recommended microorganisms were included. The methodology used for 
carrying out the annual review of the list of QPS recommended biological agents was detailed. A list 
of microbial species from previous notifications and as notified to EFSA, annexed in these opinions, 
included information on taxonomic units which are or are not recommended for the QPS list with the 
rational for this decision. This list of notifications aims to summarize and maintain important 
information for future assessments and updates and is intended to be updated annually. 
 
TERMS OF REFERENCE AS PROVIDED BY EFSA 
EFSA requests the BIOHAZ Panel to provide the: 
1. Preparation of an update of the list of biological agents notified to EFSA Units and/or Scientific 
Panels such as Pesticides, FEEDAP and GMO for intentional use in feed and/or food or as 
sources of food and feed additives, enzymes and plant protection products for safety assessment.   
2. Annual review of the list of biological agents recommended for the QPS list. Where appropriate 
new taxonomic units should be assessed for their suitability for an inclusion in the QPS list, and 
taxonomic units previously assessed should be reviewed where new information has become 
available. The information provided in the previous opinion should be updated where appropriate. 
3. Review of the qualifications for taxonomic units included in the QPS recommended list and in 
particular the qualification regarding antimicrobial resistance in taxonomic units recommended 
for the QPS list. 
4. Review and update of the body of knowledge for notified filamentous fungi and enterococci. 
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ASSESSMENT 
1. Introduction 
A wide variety of microorganisms (including viruses) are intentionally added at different stages into 
the food chain, either directly or as a source of additives or enzymes. In this context, approximately 
100 species of microorganisms have been expected to be referred to EFSA for a safety assessment. 
The majority are the result of notifications received by EFSA for market authorisation as sources of 
food and feed additives, food enzymes and plant protection products received by EFSA.  
Qualified Presumption of Safety (QPS) has recently entered EU law with the publication of a new 
Commission Implementing Regulation (EU) No 562/2012 (Commission Implementing Regulation, 
2012)
12
 amending Commission Regulation (EU) No 234/2011 (Commission Regulation, 2011)
13
 with 
regard to specific data required for risk assessment of food enzymes. If the microorganism used in the 
production of a food enzyme has a status of QPS according to the most recent list of QPS 
recommended biological agents adopted by the Authority (meaning EFSA), the enzyme application 
should not be required to include toxicological data. If residues, impurities, degradation products 
linked to the total enzyme production process (production, recovery and purification) could give rise 
for concern, the Authority, pursuant to Article 6(1) of Regulation (EC) No 1331/2008 (Regulation, 
2008)
14
, may request additional data for risk assessment, including toxicological data. 
The purpose of the present Opinion is to review the list of previously QPS recommended biological 
agents which was last established in 2012 (EFSA, 2012a). The QPS approach was developed by the 
Scientific Committee to provide a generic concept to prioritise and to harmonise risk assessment of 
microorganisms intentionally introduced into the food chain within EFSA in support of the respective 
Scientific Panels and Units in the frame of authorisations (EFSA, 2007). The list, first established in 
2007 is to be reviewed annually (EFSA, 2007). Taxonomic units were included in the QPS list either 
following notifications to EFSA or following proposals made during a public consultation in 2005 by 
stakeholders, even if they were not yet notified to EFSA (EFSA, 2005). 
1.1. QPS an assessment approach for use within EFSA  
QPS as a concept provides a generic safety pre-assessment approach for use within EFSA that could 
be applied to all requests received by EFSA for the safety assessments of microorganisms or viruses 
deliberately introduced into the food chain. The assessment covers risk for human, animals and the 
environment. In the case of viruses used for plant protection purposes the QPS assessment does not 
cover the environmental impact. Its introduction would harmonise and make the risk assessment 
approach more transparent across the EFSA Scientific Panels and Units. It would aid the consistency 
of assessments and make better use of resources by focussing on those organisms, which present the 
greatest risks or uncertainties (EFSA, 2005, 2009a). 
In the QPS concept a safety assessment of a defined taxonomic unit is considered independently of 
any particular specific notification in the course of an authorisation process. If the taxonomic unit 
                                                     
 
12  Commission Implementing Regulation, 2012. Commission Implementing Regulation (EU) No 562/2012 of 27 June 2012 
amending Commission Regulation (EU) No 234/2011 with regard to specific data required for risk assessment of food 
enzymes. OJ L 168, 28.6.2012, p. 21-23. 
13  Commission Regulation, 2011. Commission Regulation (EU) No 234/2011 of 10 March 2011 implementing Regulation 
(EC) No 1331/2008 of the European Parliament and of the Council establishing a common authorisation procedure for 
food additives, food enzymes and food flavourings. OJ L 64, 11.3.2011, p. 15-24. 
14  Regulation, 2008. Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 
establishing a common authorisation procedure for food additives, food enzymes and food flavourings. OJ L354, 
31.12.2008, p. 1-6. 
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does not raise any safety concerns, or if existing safety concerns can be clearly defined as specific 
qualifications to ensure their absence (exclusion) in the context of a specific notification, a particular 
taxonomic unit could be recommended for the QPS list. Subsequently, any specific representative of a 
QPS proposed taxonomic unit, would not need to undergo a further safety assessment other than to 
satisfy any of the qualifications specified if applicable. Representatives of taxonomic units that fail to 
satisfy a qualification would be considered unfit for the QPS list and would remain subject to a full 
safety assessment, in the frame of a notification by the responsible EFSA Scientific Panel (EFSA, 
2007). 
The QPS concept does not address hazards linked to the formulation or processing of the products 
based on biological agents added into the food or feed chain. Neither safety of users handling the 
product nor genetic modifications are taken into account. These aspects are assessed, where 
applicable, separately by the EFSA Panel responsible for assessing the notification.  
Concerning microorganisms discussed in previous Opinions, the continuously evolving body of 
knowledge possibly reveals new information that could lead to a modification of the list of QPS 
recommended taxonomic units, for example to an ex- or inclusion of taxonomic units on the list. An 
assessment of taxonomic units, not previously considered for the QPS list, and for which 
representatives are notified to EFSA is included. Biological agents in this context include 
microorganisms and viruses used in the context of plant protection. Consequently, the QPS 2013 
update will review these biological agents. Biological agents intended for usages outside the remit of 
EFSA, and biological agents which have not been notified to EFSA, are not considered in this 
Opinion. 
Antimicrobial resistance was introduced as a possible safety concern for the assessment of the 
inclusion of bacterial species in the QPS list (EFSA, 2008). In the 2009 QPS Opinion (EFSA, 2009b) 
a qualification regarding absence of antimycotic resistance for yeast was introduced. The 
qualifications are reviewed and discussed in the present Opinion.  
The list of QPS recommended biological agents is reviewed and updated annually. Therefore, the only 
valid list is the one from the most recent scientific opinion.  
In accordance with the recommendation by the Scientific Committee that the QPS concept should be 
implemented within EFSA where relevant, an impact assessment of the use of the QPS pre-assessment 
for risk assessments by EFSA’s Scientific Units or Panels in the frame of authorisations and its 
quotation in the scientific literature is provided. 
1.2. Experience of using the QPS assessment by EFSA’s Scientific Units and Panels  
The QPS approach has proved to be a useful tool to harmonise and prioritise safety assessment within 
EFSA and is appreciated by both assessors and applicants. The QPS recommended list was mainly 
used by EFSA’s Panel on Additives and Products of Substances used in Animal Feed (FEEDAP). If a 
biological agent is recommended for the QPS list it should cover the safety for the target animal 
species, the consumers of products derived from animals treated with the additives, and the 
environment. Neither safety of users handling the product nor genetic modifications are taken into 
account. In the respective FEEDAP Opinions dealing with QPS recommended microorganisms, a 
standard sentence is included that the active agent in question is considered by EFSA to be suitable 
for the QPS approach to safety assessment. Therefore, in such case the FEEDAP Panel considers that 
no assessment of safety for the target species, consumer and the environment is required.  
Following requests from applicants, the European Commission requested EFSA to provide an opinion 
on the implications of the deletion of the maximum dose applied to those authorised microbial 
products for which safety was assessed using the QPS approach and, more generally to all 
QPS 2013 update  
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microorganisms for which this approach is used. Since the QPS assessment is not related to a specific 
purpose but has to take account of any reasonable use of the organism under consideration, and since 
all QPS assessments have been made independently of the dose, the FEEDAP Panel concluded that 
unless a specific provision relating to dose is included in the ‘qualification’ for a given taxonomic 
unit, safety is presumed at any reasonable dose (EFSA, 2012c).  
Until late September 2013, the QPS approach has been applied by the FEEDAP Panel, in the 
assessment of 14 assessments out of a total of 24 published opinions on the safety assessment of 
microorganisms used as feed additives (EFSA, 2012e-h, 2013a-j). 
For the Pesticide Unit, the annual QPS updates provide relevant new information from the literature 
for biological active agents currently under peer-review, which, if showing more critical or adverse 
effects, can be taken into account during the process of the peer-review or in the EFSA conclusion. 
When a microorganism is approved under Regulation (EC) No 1107/2009 (Official Journal of the 
European Union, 2009)
15
, a cycle of 10 to 15 years is foreseen for the revision of the dossier including 
new information according to the regulatory framework. This shows the usefulness of the QPS 
approach as a mean of regularly updating the body of knowledge on taxonomic units of importance 
for EFSA Panels and Units, even if they are not recommended for the QPS list. Hence, the annual 
update of the body of knowledge for several taxonomic units is appreciated by the Pesticide Unit.  
Biological agents recommended for the QPS list and proposed as plant protection products under the 
Council Directive 91/414/EC (Official Journal, 1991)
16
 could be exempted from certain data 
requirements such as oral toxicity data. As an example, the QPS recommendation of the 
Baculoviridae family was used during the peer review of several species of baculoviruses (EFSA, 
2012 i, j). In the scope of the pesticide assessment, the QPS recommendation does not address risks 
for the user and risks for the environment, which have to be assessed specifically for plant protection 
products according to the Regulation (EC) No 1107/2009 (Official Journal of the European Union, 
2009). The activity of maintenance of the QPS list has also been communicated to the Pesticide 
Steering Committee in March 2011.  
1.3. Reference to QPS in the scientific literature 
The EFSA 2012 Opinion cited and discussed references to the QPS approach in the scientific 
literature (EFSA, 2012a). This review was continued and some references are discussed below.  
The list of QPS recommended biological agents is reviewed and updated annually, therefore the only 
valid list is the one from the most recently published scientific opinion. However, some publications 
refer more to the general principle of QPS which has been outlined by Leuschner et al. (2010) in a 
review (Castellano et al., 2013; Castellazzi et al., 2013; Dušková and Karpíšková, 2013; Elli et al., 
2013; Fatma and Benmechernene, 2013; Fontana et al., 2013; Hrnčár et al., 2013; Klein et al., 2013; 
Nybom, 2013; Sakar, 2013; Smitha and Bhat, 2013; Sundh and Goettel, 2013; Syal and Vohra, 2013; 
Toscano et al., 2013).   
Some publications refer to the QPS assessment in analogy with the Generally Recognised As Safe 
(GRAS) concept used in the United States (Ghanban et al., 2013; Lauková et al., 2012; 
Szkaradkiewicz and Karpiński, 2013). It has to be clearly emphasised that the QPS assessment has a 
different aim. QPS is a pre-assessment intended to be considered and complemented by a safety 
                                                     
 
15  Official Journal of the European Union, 2009. Regulation (EC) No 1107/2009 of the European Parliament and of the 
Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council 
Directives 79/117/EEC and 91/414/EEC. OJ L 309, 24.11.2009, p. 1-49. 
16  Official Journal of the European Communities, 1991. Council Directive of 15 July 1991 concerning the placing of plant 
protection products on the market (91/414/EEC). OJ L 230, 19.08.1991, p. 1-32.  
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assessment of a specific notification. QPS assesses always the highest taxonomic unit possible, which 
is usually the species. It never assesses notified strains because this is within the responsibility of the 
Scientific Panel, which is mandated for the safety evaluation.  
2. Methodology  
The safety assessment of a defined taxonomic group (e.g. genus or species) could be made based on 
four pillars: establishing identity, body of knowledge, possible pathogenicity and end use (EFSA, 
2007). 
The QPS assessment is generic regarding a notified taxonomic unit intended to be intentionally added 
into the food chain at any stage. The QPS concept can also be applied to microorganisms that are used 
to produce enzymes, metabolites (e.g. amino acids), dead biomass or other specific end uses that do 
not involve live microbial cells. In this case the QPS recommendation only applies to the specific end 
use e.g. enzyme production. A QPS assessment is triggered by receipt of an application dossier by 
EFSA which requires a safety assessment. It is intended to be independent of the specific application 
dossier which remains the responsibility of the EFSA Scientific Unit or Panel to which the risk 
assessment is mandated.   
In this context the QPS recommended list might be useful for authorities assessing safety of 
microorganisms for other areas of use such as e.g. in foods for which notifications were not received 
by EFSA. Notifications received by EFSA are summarised in Appendix A of this opinion and are 
updated annually. These notifications are subject to a QPS assessment. Especially in food there are 
numerous microorganisms with technological beneficial use widely applied, which are not notified to 
EFSA and are subsequently not QPS assessed (Bourdichon et al., 2012a).   
The QPS assessment does not address hazards linked to the formulation or processing of the products 
based on biological agents added into the food or feed chain. Neither safety of users handling the 
product nor genetic modifications are taken into account. These aspects are assessed, where 
applicable, separately by the EFSA Scientific Unit or Panel responsible for the risk assessment of the 
notification. 
2.1. Taxonomy 
In the context of a notification received by EFSA for a safety assessment, the QPS assessment is 
carried out at the highest level possible of the identified taxonomic unit which is usually the species 
level although it can consider a family as a whole (EFSA, 2012a; Bourdichon et al., 2012b).  
2.1.1. Bacterial taxonomy  
Taxonomy and nomenclature of bacteria are covered by the International Code of Nomenclature of 
Bacteria (International Code of Nomenclature of Bacteria, 1992). New taxonomic units or alteration 
to the taxonomy and nomenclature are published in the International Journal of Systematic and 
Evolutionary Microbiology (IJSEM). In this journal a list appears where all ‘validly published’ 
taxonomic units are listed in the Notification List, i.e. the Approved List of Bacterial Names. Validly 
published are all taxonomic units, which are published in the IJSEM. Taxonomic units that were 
published outside the IJSEM are called effectively published. They appear after notification by the 
authors in a Validation List. Also changes in nomenclature are listed separately. These can be spelling 
errors in the original description or decisions of the Judicial Commission. A comprehensive and up-
to-date presentation of the current taxonomy and nomenclature of bacteria is given on the following 
website: LPSN (List of Prokaryotic names with Standing in Nomenclature, formerly List of Bacterial 
names with Standing in Nomenclature (LBSN)) (Euzeby, 2013). 
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2.1.2. Filamentous fungi and yeast taxonomy  
The nomenclature and taxonomy of fungi are covered by the International Code of Nomenclature for 
algae, fungi, and plants (ICN) (McNeill et al., 2012). New taxa or new taxonomic opinions are 
published in the international scientific literature following the rules of ICN. The major change is that 
the dual nomenclature with separate names for individual stages in pleomorphic fungi has been 
terminated meaning that all legitimate fungal names are treated equally for the purposes of 
establishing priority, regardless of the life history stage of the type. To be validly published new 
taxonomic units and nomenclatural changes must be registered electronically at MycoBank (2013), 
Index Fungorum (2013) and Fungal Names (2013) to avoid duplication of names and, in part, a 
quality check of the formalities. These are also useful sources for validity of published names. There 
is an ongoing debate among mycologists to protect or preserve names (Geiser et al., 2013; Hibbett and 
Taylor, 2013; Rossman et al., 2013). For practical identification of fungi a DNA barcode initiative has 
been launched (Schoch et al., 2012; Blaalid et al., 2013). As of now the general opinion is that more 
than a single gene is needed as exemplified for Aspergillus and Penicillium (Peterson, 2012) and 
Fusarium (O’Donnell et al., 2013). Without any doubt there will be a rapid development in this area 
and combined with enhanced phylogenetic analyses it is foreseen that the species concept in 
mycology will improve by being more robust. 
It was decided to keep the names as they are right now until such lists of ‘recommended species 
names’ appear in future.  The presentation of the yeast taxonomy of the 2011 QPS Opinion is still 
valid (Kurtzmann et al., 2011; EFSA, 2012a) and maintained in this update. 
2.1.3. Virus taxonomy  
The taxonomy and nomenclature of viruses are the responsibility of the International Committee on 
Taxonomy of Viruses (ICTV, 2013). Every three years an update is made based on proposals of 
working groups after adoption by the Executive Committee. The most recent update is from 
November 2011 (King et al., 2011). Virus taxonomy is based on shared characteristics such as (i) the 
type of nucleic acid (RNA or DNA), (ii) the structure of the nucleic acid (single-stranded or double 
stranded RNA or DNA), (iii) the polarity of the nucleic acid (positive stranded = translatable into 
proteins; negative stranded = nontranslatable into proteins) and (iv) the form of the virus (isometric, 
rod-shaped, filamentous or pleomorph). In addition to these characters, the replication strategy of the 
viruses is also taken into account and contributes to their taxonomic position (Baltimore, 1971, 1974). 
Viruses are organized in orders (-virales), families (-viridae), genera (-virus) and species (-virus) by 
virtue of shared characteristics as described above. Viruses do not have a common ancestor; therefore 
phylogenetic information is only partially useful in directing the taxonomy of viruses. 
2.1.3.1. Plant virus taxonomy  
Plant viruses cause disease in plants and many of these viruses are transmitted by vectors (insects, 
nematodes, fungi). The large majority of plant viruses contain positive stranded (= directly 
translatable) RNA as genetic information. About 1,000 plant virus species have been recognized and 
accommodated into two orders and 20 families (King et al., 2011; Mayo, 1999).  
2.1.3.2. Baculovirus taxonomy  
Baculoviruses are large DNA viruses occurring in members of the insect orders Lepidoptera (moths 
and butterflies), Hymenoptera (sawflies) and Diptera (flies). The family Baculoviridae is subdivided 
into four genera, Alphabaculovirus, Betabaculovirus, Gammabaculovirus and Deltabaculovirus (Jehle 
et al., 2006). Fifty baculoviruses have been officially recognized as species (King et al., 2011; ICTV, 
2013), but about 700 different baculoviruses have been described. Baculoviruses, unlike many other 
virus groups have a common ancestor assisting in the assignment of their taxonomic status.  
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2.2. Body of knowledge 
The body of knowledge concerning a defined taxonomic unit is assessed to conclude whether it is 
sufficient to reach a decision regarding its safety. The body of knowledge includes the history of use 
of a taxonomic unit, scientific literature, clinical aspects, industrial applications, ecology and other 
factors as considered appropriate. An inventory of microbial food cultures with a technological role in 
fermented food was published by the International Dairy Federation (Bourdichon et al., 2012 c, d). In 
this Opinion only scientific information was considered which can be cited in a transparent manner 
and includes sufficient description of the methodologies and the results obtained. 
2.2.1. Review of the scientific literature 
A literature review was carried out for each taxonomic unit that was notified to EFSA either for the 
QPS Opinions in 2007, 2008, 2009b, 2010, 2011a and 2012a. QPS recommended taxonomic units 
(Table 1) and those which represent an important part of the notifications are annually reviewed. For 
the taxonomic units recommended for the QPS list the time period of this review covered is the 
beginning of May 2012 until 30 April 2013 for the QPS 2013 update. For new notifications the 
literature review was broader to cover the history of use, the potential safety concerns and the 
ecology. 
Relevant databases such as PubMed, Web of Knowledge, CasesDatabase, GoogleScholar, CAB 
Abstracts or Food Science Technology Abstracts (FSTA) were searched using specific sections. 
Keywords used may equally be specified in the specific section. Some common keywords such as the 
taxonomic unit in combination with ‘toxin’, ‘disease’, ‘infection’, ‘clinical’, ‘virulence’, 
‘antimicrobial and/or antibiotic/antimycotic resistance’, ‘safety’, ‘risk’, ‘abortion’, ‘urinary’, 
‘mastitis’, ‘syndrome’, ‘vaginitis’. In addition some animal categories such as ‘poultry’, ‘chicken’, 
‘hen’, ‘broiler’, ‘turkey’, ‘fowl’, ‘piglet’, ‘pig’, ‘calf’, ‘calves’, ‘cattle’, ‘cow’, ‘fish’ and ‘salmon’ 
were generally applied. Relevant studies were evaluated, reported and discussed. The search terms 
were broad and covered synonyms or former names of taxonomic units. 
2.2.1.1. External extensive literature search (EFSA-Q-2012-00969) 
In addition to the review undertaken by the working group experts, an external extensive literature 
search was carried out in part using the methodology outlined above. 
The extensive literature search of studies related to safety concerns for humans, animals, or the 
environment of microorganisms recommended for the Qualified Presumption of Safety (QPS) 2012 
list (EFSA, 2012a) was carried out by an external contractor (EFSA-Q-2012-00969). The literature 
search involved extensive searches of the published and grey literature for selected yeasts, Gram-
positive non-sporulating bacteria, and Gram-positive sporulating bacteria. The total number of 
citations identified by the database searches was 15,349. Following de-duplication, there were 7,499 
unique citations, with one additional citation identified through a search of the reference lists of 
relevant case reports. Thus, the titles and abstracts of 7,500 citations were screened for relevance, and 
data characterization of relevant publications was undertaken. One hundred and fifty-two citations 
passed relevance screening, of which 22 were case reports. Of the 152 studies included, 88 (58 per 
cent) were identified using Science Citation Index and/or PubMed. BIOSIS Citation Index and CAB 
Abstracts appeared to be the highest yielding information sources for studies not found by Science 
Citation Index and/or PubMed. No included studies were found uniquely in Conference Proceedings 
Citation Index, TOXNET, OpenGREY or Science.gov. Ten eligible studies were found by 
ScienceResearch.com, which were not found using PubMed, Science Citation Index, BIOSIS Citation 
Index, or CAB Abstracts. ScienceResearch.com did not identify any relevant grey literature 
suggesting that its use in this context was limited.  
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The external extensive literature search confirmed the information obtained by the working group 
experts. 
2.3. Review of safety concerns identified as ‘qualification’ on the QPS list 
The assessment of antimicrobial resistance in the frame of a specific notification is within the 
responsibility of the EFSA Scientific Panel or Unit to which the notification was assigned. The QPS 
WG aims to provide general background information for their consideration and support. In particular, 
the generic qualification for all bacterial taxonomic units on the QPS recommended list is that the 
strains should not harbour any acquired antimicrobial resistance genes to clinically relevant 
antibiotics (Table 1).  
A recent EFSA review concluded that for EFSA as a whole, the use of interpretative criteria and 
methods to define and monitor antimicrobial resistance have been harmonised and are reflected in 
EFSA’s guidance documents. The use of harmonised methods and epidemiological cut-off values 
ensures the comparability of data over time at country level, and also facilitates the comparison of the 
occurrence of resistance between Member States (EFSA, 2012b). 
Absence of acquired genes coding for antimicrobial resistance for QPS recommended bacterial 
taxonomic units is a generic qualification. Generally, it has been considered for the QPS approach that 
strains carrying acquired resistances should not be intentionally introduced into the food and feed 
chain. The scope and search for the review of antimicrobial resistance is to conduct a review of each 
taxonomic unit recommended for the QPS list as it was done last year. During the last QPS update 
(EFSA, 2012a) the quality of the studies regarding antimicrobial resistance appeared to be variable. 
The approach adopted has been to consider all available information and subsequently discuss any 
potential weak points in the available studies. 
General search terms used were: ‘susceptibility’, ‘resistance’, ‘antimicrobial’ and ‘antibiotic’. 
Additional search terms are related to acquired resistance genes in line with the generic qualification 
mentioned in Table 1 ‘not harbouring any acquired antimicrobial resistance genes’ and included e.g. 
tet, blaVIM, blaKPC, blaCTX-M, vanA, vanB, vanD, vanE, vanG, vanL, vanM, aac, aph, aad, arm, rmt, 
erm, lnu, vat, vga, ere, mef, mre, msr, mph, lin, lsa, cfr, sul, dhfr, cat, flo, flex, qep, qnR, oqxAB. This 
list is not exhaustive. 
2.3.1. Other qualifications 
Several Bacillus species are on the QPS list with the qualification ‘absence of toxigenic activity’. This 
is based on the observation that some rare strains among the Bacillus species on the QPS list have 
caused food borne intoxication in the past, and that these intoxications have been attributed to the 
production by these strains of compounds with toxic activities. A technical guidance to identify these 
toxic compounds among Bacillus species has been elaborated by EFSA (EFSA, 2011b) which is at 
present updated. The application of the qualification should permit to identify this safety concern 
among strains of the QPS Bacillus species. It is the purpose of the annual update of the QPS list to 
verify that no other relevant safety concerns have been identified for the QPS Bacillus species.  
Enterococcus faecium was considered in the last QPS review (EFSA, 2012a) because members of this 
species are authorized in the EU as feed additives to improve growth performances of animals. In the 
last years the EFSA safety assessment of these microorganisms was made at strain level, assessing the 
absence of putative virulence factors and acquired antibiotic resistance determinants. In 2012 EFSA 
has issued the Guidance on the safety assessment of Enterococcus faecium in animal nutrition (EFSA, 
2012d), based on the most recent genomic, phylogenetic and epidemiologic data. This approach 
introduces safety criteria such as the susceptibility to the antibiotic ampicillin and the absence of three 
genetic markers associated with virulence, which permits to differentiate between safe and the 
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potentially harmful strains belonging to the hospital associated subpopulation of this species to add 
practical application of this guidance on the safety assessment of Enterococcus faecium species 
(EFSA, 2012d). The purpose of the annual update of this species is to continuously assess the 
available scientific information on the taxonomy and safety of Enterococcus faecium and to consider 
if it suffices to give this species a QPS recommendation.  
3. Gram-positive non-sporulating bacteria 
3.1. Antimicrobial resistance aspects of QPS lactic acid bacteria in general  
There are specific aspects mentioned in the subchapters below. Nothing substantial new concerning 
the genus level (EFSA, 2012a) could be identified and the following is still valid. 
Antimicrobial resistance is an issue in lactobacilli and other lactic acid bacteria (LAB) and should be 
assessed according to international standards and guidelines (e.g. ISO/DIS 10932/IDF223, 2010) and 
Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 2007). For the purpose of QPS 
the FEEDAP guidance document (EFSA, 2012b) is of further relevance. 
There are several reviews and studies describing the antibiotic resistance of Lactobacillus species as 
well as other LABs (Hummel et al., 2007; Kastner et al., 2006; Klare et al., 2007; Klein, 2011; Liu et 
al., 2009; Zonenschain et al., 2009). Intrinsic resistance could be shown mainly for aminoglycosides, 
quinolones, and glycopeptides (Hummel et al., 2007; Klein, 2011). Moreover, the transfer of 
antibiotic resistance within LAB isolates from food has been recently studied (Nawaz et al., 2011; 
Toomey et al., 2010). Presence of genes coding for antibiotic resistances, such as tet (including 
tet(M), tet(O), tet(S), tet(W), tet(K), tet(L)) and erm (including ermA, ermB and ermC) (Ammor et al., 
2008; Hummel et al., 2007; Ishihara et al., 2013) have been reported. This is a non-comprehensive 
list. 
3.2. Bifidobacterium species 
Bifidobacteria, as other beneficial and commensal bacteria can occasionally be associated with local 
infections or severe systemic infections, as has been demonstrated in previous EFSA opinions (EFSA, 
2012a). Only one new case report of a septicaemia with Bifidobacterium longum and Bifidobacterium 
infantis was identified (Jenke et al., 2012). The patient was an extremely low-birthweight infant. The 
patient was under probiotic therapy with a product containing Lactobacillus acidophilus and 
Bifidobacterium infantis. This is another typical case report, which can be found in immune 
compromised hosts. These reports do not change the status of bifidobacteria as safe microorganisms 
in general. 
In conclusion, there is no need to change the QPS recommendation of the previously recommended 
Bifidobacterium species. 
3.2.1. Antimicrobial resistance aspects regarding the qualification 
No new antimicrobial resistance aspects were reported for bifidobacteria since the last update (EFSA, 
2012a). 
3.3. Corynebacterium glutamicum  
A literature review did not reveal new information about adverse health effects or safety concerns 
with regards to the last update (EFSA, 2012a). The QPS recommendation has been confirmed. 
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3.3.1. Antimicrobial resistance aspects regarding the qualification 
No new relevant information in the last year was published on the antimicrobial susceptibility or 
resistance of Corynebacterium glutamicum, therefore no modifications in the qualification of the 
antimicrobial resistance are proposed. 
3.4. Enterococcus faecium  
Enterococci are commensal bacteria of the gastrointestinal tract of humans and other mammals, and 
are frequently found as members of the bacterial communities of food fermentations. Among these, 
Enterococcus faecium is the most encountered species in food fermentations, such as cheese, 
fermented vegetable and sausages. This microorganism is also intentionally introduced in the food 
chain as a feed additive (animal probiotic), under a specific EU Regulation (Regulation (EC) No 
1831/2003 (Official Journal, 2003)
17
, which requires risk assessment by EFSA, or as food starter 
culture.  
Antibiotic resistant strains of Enterococcus faecium are also a leading cause of infections in 
hospitalized or immune compromised patients, being responsible for endocarditis, urinary tract 
infections, or abdominal/pelvic infections resulting from contamination by the faecal microbiota. 
Human infections caused by enterococci outside the healthcare setting are very uncommon (Murray, 
2000). 
The assessment of Enterococcus faecium for QPS has been performed by EFSA in 2012 (EFSA, 
2012a), reaching the conclusion that although a differentiation between the clade containing strains 
associated to clinical infections from the clade composed by commensal strains is possible, this 
knowledge was too recent knowledge for a QPS recommendation, considering the past evolution of 
the epidemiology of Enterococcus infections in humans. This scientific information was used by the 
FEEDAP panel (Guidance on the safety assessment of Enterococcus faecium in animal nutrition, 
(EFSA, 2012d)) to issue in 2012 a scientific opinion with the aim to exclude Enterococcus faecium 
strains belonging to the hospital-associated clade from the use in animal nutrition because of the 
hazard they present to a vulnerable subpopulation of consumers. Strains to be used in animal nutrition 
shall be susceptible to ampicillin (MIC ≤ 2 mg/L) and shall not harbour the genetic elements IS16, 
hylEfm, and esp. This is of value for the FEEDAP Scientific Panel dealing with the strain specific 
notification, but it is too recent knowledge for a QPS recommendation, considering the recent 
information on the evolution of the epidemiology of Enterococcus infections in human. 
In this last year, additional genomic and phylogenetic data support the view that Enterococcus 
faecium species consists of two distinct lineages or clades. One subpopulation, clade B consists 
predominantly of human gut commensals and is characterized by susceptibility to ampicillin. The 
other subpopulation, named clade A contains most of the clinical isolates (Willems and van Schaik, 
2009; Galloway-Peña et al., 2011; Galloway-Peña et al., 2012, Palmer et al., 2012; de Been et al. 
2013). Genomic analyses demonstrated that differences between the two clades depends on an 
evolutionary divergence that occurred at least 300,000 years ago (Galloway-Peña et al., 2012) and on 
more recent recombination events, which mainly affect the strains of clade A (de Been et al., 2013), 
which seem more prone to receive foreign DNA. 
Clinical isolates of clade A are characterized by resistance to ampicillin (MIC > 4 mg/L), related to 
the presence of the allelic form pbp5-R form of the gene coding for the penicillin binding protein 5 
(PBP5) and by the presence of a putative phosphotransferase system contributing to the intestinal 
colonisation during antibiotic treatments (Zang et al., 2013). An additional differential factor between 
                                                     
 
17  Official Journal of the European Union, 2003. Regulation (EC) No 1831/2003 of the European Parliament and of the 
Council of 22 September 2003 on additives for use in animal nutrition. OJ L 268, 18.10.2003, p. 29-43. 
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the two clades is the presence in strains from human infections of the insertion sequence IS16 (Leavis 
et al., 2007; van Schaik et al., 2010; Werner et al., 2011), which presumably confers a level of 
genomic flexibility, and the esp pathogenicity island ICEEfm1 (van Schaik et al., 2010; Top et al., 
2011, 2013).  
3.4.1. Antibiotic resistance aspects regarding the qualification 
The rise in prevalence of Enterococcus faecium in human infections has coincided with the 
emergence of drug or multi-drug resistant strains. The antibiotic resistances in this species may be 
both intrinsic or acquired. Thus, this species shows intrinsic resistance to several antibiotics, e.g. low-
level resistance to streptogramin B and aminoglycosides and resistance to beta-lactams, typical of 
strains of clade A (Hollenbeck and Rice, 2012). Mobile genetic determinants conferring resistance to 
different classes of antibiotics such as aminoglycosides [aph(3’)-III, aac(6’) and aph(2’’) variants], ß-
lactams (bla, pbp5), glycopeptides (vanA/B/D/E/G/L/M), phenicols (cat genes), tetracyclines 
(tetO/L/K/S/U), oxazolidinone, lincosamides, pleuromutillins and streptogramin A (cfr) and to 
macrolides, lincosamides and streptogramins group (ermA/B/C/F/T, lnuB, vatB/D/E, msrA/C/D, lsaA, 
vgaB and mefA) have been observed in enterococci from different sources, including in food 
producing animals and food strains. The intrinsic and acquired mechanisms of resistance to 
antimicrobials have been review by Hollenbeck and Rice (2012).  
Conclusions on a recommendation for the QPS list 
Enterococcus faecium is not recommended for the QPS list in spite of the rapidly evolving scientific 
knowledge allowing a differentiation of pathogenic strains from non-pathogenic strains within this 
species. This is however of value for the FEEDAP Scientific Panel dealing with the strain specific 
notification.   
3.5. Lactobacillus species  
There were several case reports including lactobacilli and infections of immunocompromised hosts. 
Especially the species Lactobacillus rhamnosus is mentioned in some reports. This confirms the 
observation in the previous QPS reports (EFSA, 2008, 2012a) and observations in the literature 
(Klein, 2011), that Lactobacillus rhamnosus is the most prevalent species in Lactobacillus associated 
human infections. Case reports involving immunocompromised hosts were given for Lactobacillus 
delbrueckii (Duprey et al., 2012), Lactobacillus iners (Murata et al., 2012), Lactobacillus acidophilus 
(Nishijima et al., 2012; associated with dental caries, most probably misidentified instead of 
Lactobacillus gasseri) and Lactobacillus spp. not further characterised (Hamadah et al., 2013).  
Concerns about the use of probiotics within a clinical settlement was raised by several authors, e.g. by 
Vahabnezhad et al. (2013), where a 17-year-old immunocompromised boy with ulcerative colitis was 
treated with Lactobacillus rhamnosus GG and exhibited a bacteraemia with this strain. The authors 
point to the risk in applying probiotics to immunosuppressed patients with severe active ulcerative 
colitis. However, this use is not the normal use for QPS taxonomic species. Lactobacillus rhamnosus 
GG has been previously involved in similar clinical circumstances. A 95-year old woman with 
underlying chronic diseases exhibited an infection in a prosthetic joint with Lactobacillus casei and 
Lactobacillus paracasei (Orkaby et al., 2012). The identification to species level was not described. 
Yoghurt containing Lactobacillus casei could be confirmed in her diet, but the etiological connection 
could not be made.  In a retrospective study Simkins et al. (2012) explored the incidence of probiotic-
related bloodstream infections due to Lactobacillus acidophilus or Lactobacillus bulgaricus in a large 
medical centre. They stated only a minimal risk of such infections.  
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The reports identified in the external extensive literature search were either not related to clinical 
infections (Abubacker et al., 2012) or were isolated from sputum of different patient groups with 
underlying disease but with no etiological connection to the microbiological finding (Popoca et al., 
2012). They were thus not furthermore considered.  
In conclusion, there is no need to change the QPS recommendation of the previously recommended 
Lactobacillus species, but clinical infections including lactobacilli species, especially Lactobacillus 
rhamnosus, should be closely monitored. 
3.5.1. Antimicrobial resistance aspects regarding the qualification 
The external extensive literature search identified two reports with reference to antibiotic resistance in 
lactobacilli. Giri et al. (2012) did not find antibiotic resistances in a strain of Lactobacillus plantarum 
isolated from fish and intended to be used as probiotics. On the other hand, Turchi et al. (2013) found 
a tetracycline resistant phenotype in 6 of 42 wild Lactobacillus plantarum strains intended to be used 
as a probiotic. These findings emphasise the qualification of absence of transferable, acquired 
resistance genes for QPS strains. 
3.6. Lactococcus species  
Lactococcus lactis subsp. lactis and Lactococcus lactis subsp. cremoris are common starter organisms 
used worldwide in dairy industry and have been included in the QPS list, despite of isolated human 
and animal clinical cases involving Lactococcus lactis that have been reported (EFSA, 2012a). A 
search in PubMed revealed three new human cases, a necrotic abscess in a middle-aged patient 
(Hadjisymeou et al., 2013), an early postoperative infective endocarditis caused in a 75-year-old man 
(Rostagno et al., 2013) and an atypical necrotising pneumonia (Buchelli-Ramirez et al., 2013).  In the 
first two studies the authors did not describe the method used for species identification, while a 
phenotypic approach was used for the taxonomical identification of the strain isolated from 
necrotising pneumonia. 
The recent findings do not warrant a reconsideration of the QPS recommendation of Lactococcus 
lactis, which is maintained. 
3.6.1. Antimicrobial resistance aspects regarding the qualification 
No new relevant information in the last year was published and the genus is covered by general 
section on lactic acid bacteria (3.1.). There is no new information that would require a modification in 
the qualification of the antimicrobial resistance. 
3.7. Leuconostoc species  
Four species of the genus Leuconostoc (Leuconostoc citreum, Leuconostoc mesenteroides, 
Leuconostoc lactis and Leuconostoc pseudomesenteroides) were previously given a QPS 
recommendation.   
Since 2012, a single new case of Leuconostoc lactis infection was reported in a patient who had 
undergone to liver transplantation. The identification of the infective agent was properly performed 
using phenotypic tests and 16S rDNA gene sequence analysis (Deng et al., 2012).  
In conclusion, QPS recommendations for Leuconostoc citreum, Leuconostoc lactis, Leuconostoc 
mesenteroides and Leuconostoc pseudomesenteroides are given. 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 19 
3.7.1. Antimicrobial resistance aspects regarding the qualification 
No new relevant information in the last year was published and the genus is covered by general 
section on lactic acid bacteria (3.1.). There is no new information that would require a modification in 
the qualification of the antimicrobial resistance. 
3.8. Pediococcus species  
One case report involving a not further identified Pediococcus spp. isolate could be found, where a 
tumor patient exhibited a necrotizing infection after rupture of the tumor (Michalopoulos et al., 2013).  
In conclusion, there is no need to change the QPS recommendation of the previously recommended 
Pediococcus species. 
3.8.1. Antimicrobial resistance aspects regarding the qualification 
No new antimicrobial resistance aspects were reported for pediococci in the external extensive 
literature search since the last update (EFSA, 2012a). 
3.9. Oenococcus oeni  
No new reports for clinical infections were found for Oenococcus oeni and also in the external 
extensive literature search no new reports were cited since the last update (EFSA, 2012a). 
Therefore, there is no need to change the QPS recommendation of the previously recommended 
Oenococcus species. 
3.9.1. Antimicrobial resistance aspects regarding the qualification 
No new antimicrobial resistance aspects were reported for oenococci in the external extensive 
literature search since the last update (EFSA, 2012a). 
3.10. Dairy propionic acid bacteria 
No new reports for clinical infections were found for dairy propionic acid bacteria and also in the 
external extensive literature search no new reports were cited since the last update (EFSA, 2012a). 
Therefore, there is no need to change the QPS recommendation of the previously recommended dairy 
propionic acid bacteria species. 
3.10.1. Antimicrobial resistance aspects regarding the qualification 
No new antimicrobial resistance aspects were reported for dairy propionic acid bacteria in the external 
extensive literature search since the last update (EFSA, 2012a). 
3.11. Streptococcus thermophilus  
No reports of clinical infections related to Streptococcus thermophilus were identified in scientific 
literature since 2012. The name Streptococcus thermophilus is considered as the correct basonym for 
Streptococcus salivarius subspecies thermophilus. Therefore, the QPS recommendation for this 
species is maintained. 
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3.11.1. Antimicrobial resistance aspects regarding the qualification 
Although little scientific information is still available on the Streptococcus thermophilus 
susceptibility to clinically relevant antibiotics, the presence of acquired resistance genes in this dairy 
bacterium has been reported. For example, the presence of acquired resistance genes, the 
erythromycin resistance determinant ermB and the tetracycline-resistance genes tet(S), tet(M), and 
tet(L) and aminoglicoside resistance determinants ant(6) and aph(3’)-IIIa were detected in dairy 
strains of Streptococcus thermophilus (Rizzotti et al., 2009; Zhou et al., 2012). These resistances are 
covered by the general qualification on antibiotic susceptibility. There is no new information that 
would require a modification in the qualification of the antimicrobial resistance. 
4. Gram-positive spore forming bacteria  
4.1. Bacillus species  
4.1.1. Update of the body of knowledge on safety concerns for QPS Bacillus species  
In total 230 articles found by relevant search terms were screened. A bacteraemia related to a 
pacemaker wire infection was caused by Bacillus licheniformis (Idelevich et al., 2012). Bacillus 
subtilis and Bacillus licheniformis were identified as the cause of a bacteraemia in a patient with an 
oesophageal perforation (La Jeon et al., 2012). Kim et al. (2012) reported a case of bacteraemia 
caused by Bacillus licheniformis following vertebrotherapy in a patient with a lung cancer. Safety 
concerns for food producing animals were also considered in the search because ‘the body of 
knowledge about the organisms for which QPS is sought must be sufficient to provide adequate 
assurance that any potential to produce adverse effects in humans, livestock or the wider environment 
is understood and predictable’ (EFSA, 2007). A Bacillus sp. was isolated from abscesses in several 
sheep and goats, but authors could not identify the isolates to the species level by phenotypic tests and 
sequence of 16s rRNA gene (Mariappan et al., 2012). Gangrenous mastitis in several goats was 
caused by Bacillus spp., one of the isolates was identified Bacillus cereus, but other isolates were not 
identified at the species level (Mavangira et al., 2013). Bacillus subtilis was isolated, together with 
Staphylococcus, from milk of goats with subclinical mastitis (Razi et al., 2012), but without evidence 
that Bacillus subtilis was the cause of mastitis. 
These cases of infections in human are linked to specific predisposing factors and do not suggest a 
risk for the consumer via exposure through the food and feed chain. The abscesses reported in sheeps 
were not sufficiently characterized to know if Bacillus species from the QPS list were involved. For 
the mastitis in goats, the co-isolation of Staphylococcus aureus, a well-known agent of mastitis, raises 
doubt on the role of Bacillus subtilis in the infection. 
4.1.1.1. Other relevant information published on QPS Bacillus species 
A review article on foodborne illness caused by Bacillus species, including some QPS Bacillus 
species was published in 2012 (Logan, 2012). It is in line with previous QPS assessment (EFSA, 
2008) concerning the rare implication of QPS Bacillus species in foodborne illnesses, and the likely 
implication of peptidolipides with toxic activities produced by the responsible strains. Two articles 
described some biological activities of peptidolipides with biosurfactants produced by Bacillus 
subtilis. A biosurfactant produced by a strain of Bacillus subtilis caused epithelium cells vacuolisation 
and microvilli damage in the mid-gut of an insect larvae (LC50 around 200 ng/mg according to Ghribi 
et al., 2012). A Bacillus subtilis strain isolated from a Korean fermented soybean paste produced up to 
48 mg surfactin per kg in the fermented food, and the surfactin inhibited growth of human breast 
cancer cells (IC50 10µg/ml, Lee et al., 2012). 
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The above new information does not seem to affect the Bacillus related QPS qualification of ‘absence 
of toxigenic activity’. Therefore, the QPS recommendation was confirmed. 
4.1.2. Antimicrobial resistance aspects regarding the qualification  
The MIC of 85 strains, belonging to two QPS Bacillus species, Bacillus subtilis, Bacillus 
licheniformis, and to Bacillus sonorensis (a very close relative of Bacillus licheniformis (Palmisano et 
al., 2001), for chloramphenicol, clindamycin, erythromycin, gentamicin, kanamycin, tetracycline and 
vancomycin, were obtained (Adimpong et al., 2012). The strains were isolated from starters used in 
traditional African bread production. No isolates with MIC higher than the breakpoint values 
recommended by EFSA (EFSA, 2012b) were found for gentamicin, tetracycline and vancomycin, 
whereas between 50 and 100% of isolates had MIC higher than the EFSA breakpoint values for 
chloramphenicol, clindamycin, erythromycin, kanamycin and streptomycin. 
The Bacillus licheniformis isolates with MIC higher than EFSA breakpoints values for erythromycin 
presumably carried resistant genes ermD, ermK on a plasmid. Such strains would not meet the 
qualification 'absence of acquired genes for antimicrobial resistance' and would have been detected 
using the EFSA guidance (EFSA, 2012b) due to the MIC value higher than the beakpoint. ErmD and 
ermK genes were also found in one strain of Bacillus licheniformis strains with an MIC value equal to 
the EFSA break point. This strain would not be detected using EFSA guidance as carrying potentially 
acquired resistance genes to erythromycin. However, from the sequence of these two resistance genes, 
authors assumed that they are not functional.  
In conclusion, the study from Adimpong et al. (2012) stresses and confirms the importance of the 
qualification on the 'absence of acquired genes for antimicrobial resistance' for QPS Bacillus species 
introduced in the food chain. It also demonstrates the efficacy of the EFSA guidance (EFSA, 2012b) 
to detect acquired genes for antimicrobial resistance. 
In the course of an investigation on antimicrobial resistance among aquaculture bacteria, one Bacillus 
sp. isolate had MIC for chloramphenicol and streptomycin of 60 µg/ml and 100 µg/ml, respectively 
(Ozaktas et al., 2012), higher than the breakpoint of 8 µg/ml proposed for Bacillus spp. in the EFSA 
Guidance (EFSA, 2012b). Another study on aquaculture environment found Bacillus species 
(including species on the QPS list) frequently indentified among tetracycline resistant bacteria (Gao et 
al., 2012) but it is not possible from the results to determine the MIC of the Bacillus isolates. 
The publication La Jeon et al. (2012) measures the antimicrobial susceptibility of six isolates of 
Bacillus licheniformis and Bacillus subtilis using disc diffusion assays. These do not give an 
indication of presence of acquired resistance genes in these isolates. 
A new mechanism of antimicrobial resistance to cephalosporin in Bacillus subtilis was discovered 
(Lee et al., 2012). This resistance was due to a mutation on the chromosome and is not a transferable 
resistance concerned by the qualification. 
There is no new information that would require a modification in the qualification of the 
antimicrobial resistance. 
5. Gram-negative bacteria 
5.1. Gluconobacter oxydans  
This species is assessed this year for the first time.  
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5.1.1. Taxonomy 
Gluconobacter oxydans is a Gram-negative belonging to the family Acetobacteraceae (acetic acid 
bacteria). Synonyms that have been commonly employed are Acetobacter suboxydans and 
Gluconobacter suboxydans. Several subspecies have been described within the species (subsp. 
industrius, melanogenes, oxydans, sphaericus, suboxydans). Acetobacter suboxydans, Acetobacter 
oxydans and Gluconobacter suboxydans have been re-classified as Gluconobacter oxydans, and the 
names can be considered as synonyms. A phylogenetic study using 16S rRNA sequence analysis has 
described five clusters, corresponding to the major five species of Gluconobacter, namely 
Gluconobacter albidus, Gluconobacter cerinus, Gluconobacter frateurii, Gluconobacter oxydans 
(type species), and Gluconobacter thailandicus (Takahashi et al., 2006) but since then several new 
species have been described and some data obtained (Yukphan et al., 2004; 2010) suggest the 
presence of additional new species in the genus. These results suggest that the phenotypic differences 
among Gluconobacter species are ambiguous and the species definition must be re-evaluated. At this 
moment according to the LSPN fourteen species and five subspecies are included in the genus 
Gluconobacter (Euzeby, 2013). 
Gluconobacter oxydans is an obligate aerobe frequently used in classical food fermentation processes 
(vinegar production) as well as industrial biotechnology. It is widely used in biotechnological 
applications due to its capacity to incompletely oxidize a wide range of carbohydrates, alcohols and 
acids (D-sorbitol, glycerol, D-fructose, and D-glucose) using membrane-bound polyol dehydrogenases 
(De Muynck et al., 2007). Gluconobacter is not able to overoxidize acetic acid to CO2 and H2O since 
it lacks succinate dehydrogenase and the tricarboxylic acid cycle is incomplete. Final fermentation 
product is mainly acetic acid but also vitamin C, (keto)gluconic acid, and dihydroxyacetone. 
Nowadays, new processes for the synthesis of compounds have been developed to produce L-ribulose, 
D-tagatose, miglitol and chiral aldehydes and acids. Membrane-bound polyol dehydrogenases are also 
used in biosensor technology to measure substrate concentration and for co-enzyme regeneration (De 
Muynck et al., 2007). It has been also used to metabolize patulin to a less-toxic compound, ascladiol 
(Ricelli et al., 2007). As spoilage bacteria, representatives of Gluconobacter oxydans are usually 
associated to bacterial rot of fruits and the common habitat is sugar-rich environments such as fruits 
and juices. The species as well as the genus are generally considered non-pathogenic to humans or 
animals (De Muynck et al., 2007). 
5.1.2. Body of knowledge 
‘Gluconobacter oxydans’ was searched as key word (including ‘Gluconobacter’) in the topic of 
articles on the Web of Knowledge and PubMed from 1950 until September 2013. Around 1000 
references were identified in the Web of Knowledge and around 500 in PubMed. All hits were 
screened. No article mentioned human or animal safety concerns. There were only two articles that 
mentioned cases of disease caused by concomitant Gluconobacter spp. (Alauzet et al., 2011; Basetti 
et al., 2013).  
Gluconobacter oxydans was also previously known as ‘Acetobacter suboxydans’. Therefore, also 
‘Acetobacter suboxydans’ was searched as key word in the topic of articles on the Web of Knowledge 
and PubMed for the same period of time (including 'Acetobacter’). Around 2500 were found in Web 
of Knowledge and about 1250 in PubMed. All hits were screened. No article mentioned human or 
animal safety concerns. 
5.1.3. Safety assessment 
Only two articles mentioned a possible pathogenic effect of Gluconobacter spp.. One of them 
described a case of endocarditis in a patient with a history of intravenous-drug abuse involving 
Gluconobacter as a concomitant bacterium (Bassetti et al., 2013). Another study described the 
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isolation of acetic acid bacteria (AAB) from clinical samples from three patients and the clinical and 
bacteriological features of these cases. It was reported for the first time (i) the isolation of a 
Gluconobacter sp. from human clinical samples; (ii) the successive isolation of different AAB, i.e., an 
Asaia sp. and two unrelated Gluconobacter spp., from a cystic fibrosis patient; and (iii) persistent 
colonization of the respiratory tract by a Gluconobacter sp. in this patient. The main clinical features 
associated with AAB isolation identified in the 10 documented reports currently available in the 
literature were reviewed. Albeit rare, infections as well as colonization with AAB are reported in 
patients with underlying chronic diseases and/or indwelling devices. Some species (however not 
Gluconobacter oxydans) in the genus have been reported as unusual opportunistic pathogens, which 
may be multiresistant to antimicrobial agents according to only one publication (Alauzet et al., 2011). 
No article mentioned human or animal safety concerns related to consumption of foods and feed. 
Additionally, the Technical Rules for Biological Agents published by the Committee on Biological 
Agents (ABAS) in connection with occupational hazards (that complies or adapts the rules and they 
are announced by the Federal Ministry of Labour and Social Affairs in the German Joint Ministerial 
Gazette) in December 2010 (BAUA, 2013), classified all described species of Gluconobacter 
including Gluconobacter oxydans in risk class 1, therefore the lowest risk. Also the closely related 
Acetobacter and Gluconacetobacter were also placed in risk class 1.  
In conclusion, the body of knowledge of this bacterium describes its extensive presence in fermented 
foods that have been widely consumed without any reference of safety concerns related to its 
presence.  
5.1.4. Antimicrobial resistance aspects regarding the qualification 
There was no report of resistance to antibiotics in any of the papers screened.  
5.1.5. Other relevant information 
In 1982, a new antibiotic, tentatively named as AB-315 (enacyloxin), was isolated from the 
fermentation broth of a designated Gluconobacter strain W-315 (Watanabe et al., 1982a; b). A strain 
of Gluconobacter sp. producing monobactam was identified from nature and it was deposited under 
the accession number of ATCC 31,581 (Wells et al., 1982), where it appears as producer of beta-
lactam antibiotic  EM5210 (ATCC online catalogue). In the same study, several ATCC strains were 
tested and three were identified as monobactam-producing strains of Gluconobacter oxydans (Wells 
et al., 1982). These strains are deposited in the ATCC culture collection as Gluconobacter oxydans, 
however in the current ATCC online catalogue (ATCC, 2013) antibiotic production is not mentioned. 
This aspect will be followed in future QPS reviews. 
5.1.6. Conclusion regarding a QPS recommendation 
Therefore, according to all the scientific evidence examined and evaluated, Gluconobacter oxydans is 
recommended for the QPS list subject to a qualification ‘QPS only apply when the species is used for 
vitamin production’ which is relevant for the intended use for which the species was notified.  
6. Yeast 
6.1. Update of the body of knowledge on safety concerns for yeast species on the QPS list 
For the majority of the yeast species listed in the preceding QPS update (EFSA, 2012a), the literature 
update did not identify any new studies reporting potential safety concerns: Hanseniaspora uvarum, 
Kluyveromyces lactis, Kluyveromyces marxianus, Komagataella pastoris, Lindnera jadinii, Ogataea 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 24 
angusta, Saccharomyces bayanus, Saccharomyces pastorianus and Schizosaccharomyces pombe. The 
remaining four species plus Trichosporon mycotoxinivorans are treated separately below.  
6.1.1. Debaryomyces hansenii  
Beyda et al. (2013) reported two human cases of Candida famata (the anamorph of Debaromyces 
hansenii) fungemia (Houston, US). Both patients had serious underlying disease. The study indicated 
that Candida famata may exhibit reduced susceptibility to some common antimycotics, compared to 
yeasts commonly associated with opportunistic infections. Chan et al. (2013) reported isolation of 
Debaromyces hansenii from a multi-fungal consortium of all untypical species isolated from a patient 
with persistent superficial skin infection (athlete´s foot). The results of these studies do not imply new 
concerns with respect to the QPS status of Debaryomyces hansenii.   
6.1.2. Saccharomyces cerevisiae  
There is currently a big interest and many publications coming out regarding the occurrence of 
Saccharomyces cerevisiae as an opportunistic pathogen. The main reasons for this interest can be 
assumed to be its wide use in food and feed and that it is considered one of the safest microorganisms 
known.  
One study report new information on possible factors that could contribute to virulence in 
Saccharomyces cerevisiae. Llopis et al. (2012) present evidence that enhanced oxidative stress 
response is a feature in virulent clinical strains.  
Among 46 yeast isolates from oral swabs from patients with head and neck cancer undergoing 
radiotherapy, one was a Saccharomyces cerevisiae (Bulacio et al., 2012). The isolate was sensitive to 
all four tested antimycotics. In oral swabs from HIV-patients, Li et al. (2013) found that one of the 
yeast isolates (frequency = 0.3% of isolates) was a Saccharomyces cerevisiae. The isolate was 
sensitive to all four tested antimycotics. Another study (Kalkanci et al., 2012) reported 
Saccharomyces cerevisiae in clinical samples from confirmed, or in some cases suspected, 
vulvovaginal candidiasis in women. They found one isolate to be Saccharomyces cerevisiae 
(frequency 0.5%), but did not provide specific information on antimycotic resistance in that isolate. In 
these three reports, Saccharomyces cerevisiae made up a very minor portion of the clinical isolates. 
Therefore it is highly uncertain whether it actually caused the disease.  
A short case report demonstrated Saccharomyces cerevisiae fungemia, in a patient under treatment for 
acute myeloid leukaemia (Choi et al., 2012). They hypothesized that intestinal colonization likely 
preceded invasion of the intestinal wall during chemotherapy-induced enterocolitis. They concluded 
that symptomatic Saccharomyces cerevisiae infections are rare, but can occur in critically ill and 
immunocompromised patients. 
These new reports of Saccharomyces cerevisiae appearing as an opportunistic pathogen add no 
further concern with respect to its QPS status. It has to be noted that Saccharomyces cerevisiae 
subtype boulardii is contraindicated for patients of fragile health, as well as for patients with a central 
venous catheter in place (EFSA, 2007). 
6.1.3. Trichosporon mycotoxinivorans 
Trichosporon mycotoxinivorans was first isolated from termite gut in 2004 and named according to its 
properties of detoxifying some mycotoxins. The promising use of some isolates in saccharification of 
hemicellulose or in the production of active emulsifiers from different hydrophobic substrates was 
also reported (Monteiro et al., 2012).  Thirteen reports concerning Trichosporon mycotoxinivorans 
have been published since the beginning of 2012, according to a bibliographic search based on Pub-
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Med and Web of Knowledge as databases. Five publications corroborate the occurrence of 
Trichosporon mycotoxinivorans-related disorder in humans and one case of a disseminated fatal 
infection involving this yeast species was described (Hirschi et al., 2012). Based on this, 
Trichosporon mycotoxinivorans cannot be proposed for the 2013 QPS list. 
6.1.4. Wickerhamomyces anomalus (Pichia anomala) 
Purisco et al. (2012) report that Pichia anomala/Candida pelliculosa was found among bloodstream 
isolates from patients with fungemia. The study found no antimycotic resistance of concern in the 
isolate. A case of fungemia due to Candida pelliculosa/Pichia anomala in neonatal babies (five cases) 
in the same intensive care unit was reported by da Silva et al. (2013). All infections were successfully 
treated with antimycotics. These new cases of Pichia anomala as an opportunistic pathogen do not 
give further concern for its QPS status, when used in enzyme production. 
6.1.5. Xanthophyllomyces dendrorhous 
Latha and Jeevaratanm (2012) reported that carotenoids from the yeast Rhodotorula glutinis (similar 
to carotenoids from the QPS listed Xanthophyllomyces dendrorhous) showed no toxicity in a mouse 
model. They conclude that the carotenoids can be used safely as food colourant.  
6.2. Conclusions on yeasts 
The inclusion of several yeast species in the QPS list (Table 1) is mainly based on the apparent 
history of safety. Overall, the annual update of the literature gave no reason to modify the QPS status, 
including the related qualifications.  
The specific virulence factors that differentiate pathogenic yeasts from innocuous ones are not 
conclusively known. However, in the current update, a study came up pointing to an additional factor 
that could contribute to virulence in opportunistic variants of e.g. Saccharomyces cerevisiae (ability 
to cope with oxidative stress (Llopis et al., 2012). More comparative studies of virulence factors in 
opportunistic yeasts are needed before a general picture can evolve.  
Reduced sensitivity to antimycotics used for medical treatment of yeast infections is occasionally 
reported. But there were no indications in the reviewed studies that the prevalence of resistance is 
increasing in the reviewed species or that resistance is becoming a problem in the treatment of 
infections by opportunistic yeasts. 
The introduction of the one-name system for pleomorphic fungi will undoubtedly have a strong 
impact on yeast nomenclature. In those cases where there are established, separate names for both 
forms in use, the likely outcome is that one of them will eventually be given priority, according to the 
rules of the ICN (McNeill et al., 2012). The ICTF (International Commission on the Taxonomy of 
Fungi) (ICTF, 2013) has a special working group for yeasts and it is anticipated that lists of new and 
prioritised names will appear in the coming years.    
7. Filamentous fungi 
7.1. Ampelomyces quisqualis  
Ampelomyces quisqualis, a natural occurring mycoparasite, is considered as one of the best 
alternatives to chemicals against Erysiphales, the casual agents of powdery mildews. During 2012 and 
the five first months of 2013, seventeen reports dealing with Ampelomyces quisqualis have been 
identified through a literature search. These 17 publications were all devoted to the evaluation of 
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Ampelomyces quisqualis mycoparasitic activity with new insights in the mycoparasitism process such 
as the key role played by cell wall degrading enzymes (Angeli et al., 2012). No new data certifying 
the lack of toxins or toxicity against animals have been retrieved and therefore Ampelomyces 
quisqualis remains ineligible for QPS status.   
7.2. Ashbya gossypii  
During 2012 and the five first months of 2013, more than 80 reports dealing with Ashbya gossypii 
have been identified through a literature search. Two main topics were discussed in these reports: 
fungal developmental biology with the use of Ashbya gossypii as an organism model and riboflavin 
production. Ashbya gossypii is a natural overproducer of riboflavin and several of the recently 
published works aimed at identifying strategies to improve this production. The overproduction 
induced by environmental stresses, nutritional or oxidative ones, reported by Walther and Wendland 
(2012) could be one of this strategy. No new data certifying the lack of toxins or toxicity against 
animals has been retrieved and in light of this limited information, Ashbya gossypii is still ineligible 
for a QPS recommendation.  
7.3. Aspergillus species 
For the Aspergillus species listed in the QPS 2012 update (EFSA, 2012a), Aspergillus aculeatus, 
Aspergillus candidus, Aspergillus niger and Aspergillus oryzae, no new information on the lack of 
toxicity or toxins have been retrieved. The reports of mid-2012 to mid-2013 retrieved by a search in 
Thomson Reuters Web of Knowledge deal with production of the specific products, often enzymes, or 
food spoilage problems. Aspergillus species are not recommended for the QPS list. 
7.4. Beauveria bassiana and Beauveria brongniartii 
More than 540 references published between 2012 and 2013 were retrieved when the keyword 
Beauveria was used in a literature search. 512 papers were devoted to Beauveria bassiana and 26 to 
Beauveria brongniartii. This high publishing activity directly results from the use of these two 
entomopathogen fungi as bioinsecticides. Few papers (close to 20) focus on the bioactive and toxic 
metabolites, beauvericin, oosporein, destruxin and pyridovericin these fungal species are able to 
produce. A first metabolomic approach, using nuclear magnetic resonance spectroscopy, was applied 
to Cordyceps bassiana (the sexual form of Beauveria bassiana) allowing the establishment of 
metabolic profiles for both mycelia and fruiting bodies (Park et al., 2013). No case of human infection 
linked to Beauveria bassiana or Beauveria brongniartii was retrieved but the potential involvement of 
these species in keratitis was corroborated by the review of Karsten et al. (2013). Conclusion on the 
peer review of the pesticide risk assessment of the active substances Beauveria bassiana strains 
ATCC-74040 and GHA was published in 2013 in the EFSA Journal (EFSA, 2013k).  This conclusion 
highlights several data gaps that require to be filled, among which the potential of secondary 
metabolites/toxins production and the risk to non-target organisms.  
Due to the limited but recognized risk of human infection and its ability to produce toxic secondary 
metabolites, Beauveria remains ineligible for the 2013 QPS list.   
7.5. Blakeslea trispora  
The reports retrieved from a search in Thomson Reuters Web of Knowledge did not disclose any 
information on their potential to produce toxins or toxicity. In light of this limited information 
Blakeslea trispora is not recommended for the QPS list. 
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7.6. Coniothyrium minitans 
Eighteen papers dealing with Coniothyrium minitans have been retrieved in the time frame of the 
literature search. Coniothyrium minitans can parasitize the sclerotia and mycelia of Sclerotinia 
sclerotiorum and most of the former papers investigate the potential of Coniothyrium minitans as a 
bio-control agent. No information on lack of toxins or toxicity against mammals was retrieved, 
therefore this species cannot be proposed for the QPS list.  
7.7. Duddingtonia flagrans  
Duddingtonia flagrans is recognized as a nematophagous fungus and its potential for biological 
control of nematode parasites of different livestock was the main subject of the 34 publications 
retrieved through the literature search in the time frame April 2012 to May 2013. Among these 34 
papers, the review of Benyon (2012) highlights the necessity to further investigate the potential 
environmental impact of this biocontrol agent that, for instance, is indiscriminate in its nematode 
infection and could reduce beneficial soil populations. No new data have been published concerning 
the potential of flagranones production by Duddingtonia flagrans neither the toxicity of these 
cyclohexenoxide antibiotics. No new data certifying the lack of toxins or toxicity against animals has 
been retrieved and Duddingtonia flagrans remains ineligible for QPS status.   
7.8. Fusarium species 
With more than 7000 references retrieved when the keyword Fusarium was used in the literature 
search in the time frame May 2012 to April 2013, the Fusarium genus is still one of the most 
extensively studied. Publications involving Fusarium deal with numerous research fields including 
plant pathology, mycology, mycotoxicology, biotechnology and medicine. Three significant points 
have to be highlighted: (i) the first published reaction of the Fusarium scientific community to the 
recent changes in the international code of nomenclature for algae, fungi and plant, (ii) the first 
attempts to develop integrated system approaches applied to Fusarium mycotoxin production and (iii) 
numerous studies illustrating the frequent occurrence of ‘Fusarium emerging mycotoxins’. Fusarium 
species are not recommended for the QPS list. 
7.8.1. Taxonomy 
In the QPS 2012 update, a special paragraph was devoted to recent important changes for mycological 
systematics. The desire of mycologists to adopt one name for each fungal species was recognized by 
the Amsterdam Declaration of Fungal Nomenclature (Hawksworth, 2011). If such an approach will 
reduce confusion arising from dual nomenclature system relating to pleomorphism in fungi 
(Wingfield et al., 2012), it raises the issue of ‘one fungus, which name?’. In recent publications 
(Geiser et al., 2013; Rossman et al., 2013), the impact of these new systematic rules for the Fusarium 
genus is discussed. 
7.8.2. Biosynthetic pathways of Fusarium mycotoxins and their regulation 
The significant progress on Fusarium mycotoxin regulation achieved during the last decade of 
research (as described in the QPS 2012 update (EFSA, 2012a)) has led to the early foundations 
required for developing system biology approaches. Disentangling and modelling the biological 
networks involved in the biosynthesis of Fusarium mycotoxins could significantly improve 
prevention strategies to control mycotoxins contamination of food and feed. These promising 
developments are the subject of a recent review published by Subramaniam and Rampitsch (2013) and 
a first study restricted to the impact of some environmental factors on fumonisin production (Medina 
et al., 2013). 
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7.8.3. Emerging Fusarium toxins 
More than 150 recent publications were retrieved by a literature search when the key words Fusarium 
and enniatin, Fusarium and beauvericin, Fusarium and moniliformin, Fusarium and fusaproliferin 
were combined. These publications were mainly reports on their occurrence in several matrices, 
cereals but also dried fruits (Tolosa et al., 2013) or on the improvement of analytical methods (mainly 
multi-toxins analysis).  
7.9. Gliocladium catenulatum  
The current name in use for Gliocladium catenulatum is Clonostachys rosea f. catenulata and the 
taxonomic relationship as well as nomenclature is described in detail (EFSA, 2009b). In light of the 
recent change in nomenclatural rules the genus Clonostachys is proposed to be protected against 
Gliocladium and Bionectria (Rossman et al., 2013). No information on lack of toxins or toxicity 
against mammals is reported, therefore this species cannot be proposed for the QPS list. 
7.10. Isaria fumosorosea (syn. Paecilomyces fumosoroseus)  
Since the most recent QPS opinion update in 2009, more than 250 reports dealing with Isaria 
fumosorosea (formerly Paecilomyces fumosoroseus) have been identified through an intensive 
literature search. These publications were identified using Isaria fumosorosea or Paecilomyces 
fumosoroseus as key words. The major part of these publications concerns the potential use of strains 
belonging to this species as biocontrol agents. Isaria fumosorosea which is an entomopathogenic 
fungus with a relatively wide host range is described as one of the most promising fungal species for 
control of diamondback moth, whiteflies and other insect pests. A recent conclusion on pesticide peer 
review was published by EFSA (EFSA, 2012k). This review concerns the pesticide risk assessment of 
the use of a Paecilomyces fumosoroseus strain as an insecticide in glasshouses on tomatoes. The 
literature search performed for this QPS review in the time frame 2009-2013 did not retrieve case 
report of human mycotic infection ascribed to Isaria fumosorosea.  
The potential of several isolates of Isaria fumosorosea to produce the beauvericin mycotoxin, which 
is toxic for humans, was however corroborated by the report of Luangsa-Ard et al. (2009). Isaria 
fumosorosea cannot be proposed for the 2013 QPS list. 
7.11. Lecanicillium muscarium  
Reports which were from a literature search did not reveal any new data on toxins or safety, therefore 
this species cannot be proposed for the QPS list. 
7.12. Metarhizum anisopliae  
The reports on Metarhizum anisopliae retrieved by a literature search deal with toxicity towards 
insects and the genetic and physiological regulation of the metabolism. There have not been retrieved 
any reports on lack of toxins or toxicity, therefore Metarhizum anisopliae cannot be proposed for the 
QPS list. 
7.13. Paecilomyces lilacinus  
The egg-parasitic fungus Paecilomyces lilacinus, a common soil hyphomycete, is a recognized 
efficient fungus for the control of root-knot nematodes Meloidogyne spp.. The majority of the 109 
reports devoted to Paecilomyces lilacinus that have been published since the beginning of 2012 
investigate its usefulness as a biocontrol agent. When the key words ‘human and infection’ were used, 
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12 papers reporting invasive human infection cases involving this opportunistic fungal pathogen were 
retrieved. Cutaneous infections were the most frequently reported cases (Keshtkar-Jahromi et al., 
2012; Lavergne et al., 2012, Rimawi et al., 2013). Due to recognised human infection disorders, 
Paecilomyces lilacinus cannot be proposed for the 2013 QPS list.  
7.14. Penicillium species 
No new information on the lack of toxicity or toxins has been retrieved through a search in Thomson 
Reuters Web of Knowledge. For the Penicillium species listed in QPS 2011 update (EFSA, 2011a), 
Penicillium camemberti, Penicillium chrysogenum, Penicillium funiculosum, Penicillium nalgiovense 
and Penicillium roqueforti the reports deal with production of the specific products or food spoilage 
problems, therefore these species still are ineligible for a QPS recommendation. 
7.15. Phlebiopsis gigantea  
The recent search in Thomson Reuters Web of Knowledge did not reveal any new information of the 
general lack of toxicity of Phlebiopsis gigantea. Conclusion on the peer review of the pesticide risk 
assessment of the active substances Phlebiopsis gigantea strains was published in 2013 in the EFSA 
Journal (EFSA, 2013l). This review highlights several data gaps to be filled, such as the potential of 
secondary metabolites/toxins production and the risk to non-target organisms. The knowledge 
concerning the capacity of Phlebiopsis gigantea to produce biological active secondary metabolites 
remains therefore insufficient and this species cannot be proposed for the QPS list. 
7.16. Pseudozyma flocculosa  
The recent search for new information on metabolites or lack of toxicity did not retrieve any new 
relevant data for this organism. The body of knowledge is insufficient to recommend Pseudozyma 
flocculosa for the QPS list. 
7.17. Trichoderma species  
Nearly 1000 papers dealing with the genus Trichoderma have been retrieved in the time frame of the 
search. This substantial publishing activity mainly results from capacity of some species to produce 
large amounts of cellulolytic enzymes (440 reports) and the promising use of several Trichoderma 
species as biocontrol agents (90 reports). 
7.17.1. Taxonomy 
The taxonomy of Trichoderma is constantly being improved by frequent publications on enhanced 
species descriptions based on phylogenetic analyses. These endeavours do not have any impact on 
taxonomic designations of species notified to EFSA. In light of the one name nomenclature for fungi 
it is proposed to protect the use of Trichoderma against Hypocrea (Rossman et al., 2013). 
7.17.2. Trichoderma asperellum  
A literature search retrieved twenty-nine reports dealing with Trichoderma asperellum. Among these 
new papers, there were no relevant publications on the lack of toxicity or toxin production: in contrast 
production of peptaibols and the pyranone volatiles have been reported (Chen et al., 2013; Wickel et 
al., 2013). Most reports investigate the diversity of promising industrial use, which this species offers. 
The potential of Trichoderma asperellum as a biocontrol agent was the subject of several publications 
and patents, with for instance, an evaluation of control of potato wilt (Ommati and Zaker 2012). 
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Conclusion on the peer review of the pesticide risk assessment of the active substances Trichoderma 
asperellum strains was published in 2013 in the EFSA Journal (EFSA, 2013m). This review 
highlights several data gaps to be filled, such as the potential of secondary metabolites/toxins 
production and the risk to non-target organisms. 
Based on the reports that Trichoderma asperellum is able to produce biological active secondary 
metabolites this species cannot be recommended for the QPS list.  
7.17.3. Trichoderma atroviride  
More than 500 papers were retrieved by a literature search with about half of them published within 
the last five years. Many scientific papers and patents published within recent years describe the 
potential of Trichoderma atroviride as an efficient biological control agent. Due to taxonomic 
confusion in the past this species has not been recommended for the QPS list (EFSA, 2009b); recently 
production of biological active peptaibols have been demonstrated (Degenkolb et al., 2012; Carroux 
et al., 2013), whereas none reports lack of toxicity or toxin production.  
In conclusion, Trichoderma atroviride cannot be recommended for the QPS list. 
7.17.4. Trichoderma citrinoviride  
Due to taxonomic confusion isolates of Trichoderma citrinoviride may have been mis-identified in the 
past, which may explain that only 62 reports were retrieved by the literature search. Recently, the 
taxonomic delimitation of this species has been updated by Samuels et al. (2012) elaboration on 
previous work (Samuels et al., 1998). Several reports exploit the extra-cellular enzymes of T. 
citrinoviride for bioconversion and bioenergy production (e.g. Chandra et al., 2013; Toth et al., 2013), 
but as production of biological active peptaibols have been reported (Maddau et al., 2009), this 
species cannot be recommended for the QPS list. 
7.17.5. Trichoderma koningii  
Trichoderma koningii is a very well known species reported in nearly 900 references retrieved by a 
literature search. The taxonomic clarification of this and related species was published some years 
ago (Samuels et al., 2006) and is still used today. This species is reported to be useful to biological 
control of insects and other pathogens but also exploited for its production of enzymes. Trichoderma 
koningii has been reported to produce biological active peptaibols (Song et al., 2006), therefore this 
species cannot be recommended for the QPS list. 
7.17.6. Trichoderma longibrachiatum  
The majority of the twenty-nine papers that were retrieved by the literature search is concerning plant 
cell wall degrading enzymes (xylanase, cellulase, etc.). Among the retrieved information there were 
no concluding reports on the occurrence or lack of toxic secondary metabolites; however there was 
one report on Trichoderma longibrachiatum infection (Rodriguez Peralta et al., 2013).  According to 
the insufficient information on the production of biological active secondary metabolites and the 
occurrence of clinical infection events, Trichoderma longibrachiatum cannot be given a QPS 
recommendation. 
7.17.7. Trichoderma reesei 
Trichoderma reesei is widely used for enzyme production and the need for toxicological evaluations 
was long time reported (Blumenthal, 2004). Since the QPS update in 2009 more than 1200 scientific 
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papers on Trichoderma reesei (syn. Hypocrea jecorina) have been published. Following publication 
of the Trichoderma reesei genome paper (Martinez et al., 2008), numerous gene clusters encoding 
biosynthetic pathways for secondary metabolites have been identified (Mukherjee et al., 2011). 
Among these gene clusters, the genes for non-ribosomal peptide synthetases (NRPSs) are the most 
important. These enzymes produce peptaibol compounds, which are known to disintegrate cell 
membranes causing apoptosis (Brückner and Graf, 1983). Degenkolb et al. (2012) demonstrated the 
production of more peptaibol families by Trichoderma reesei strains. At least eleven polyketide 
synthase gene clusters have been predicted in Trichoderma reesei; however, the products of these 
remain unknown (Baker et al., 2012). 
The capacity of Trichoderma reesei to produce peptaibols and additional compounds with unknown 
biological activity makes Trichoderma reesei ineligible for QPS. 
7.17.8. Trichoderma viride  
Trichoderma viride is widely known for its production of cellulases and the beneficial use as a 
biological control agent. This is also reflected in the 165 papers and patents that were retrieved by the 
literature search. The production of peptaibols reported in the Opinion of 2012 (EFSA 2012a) has 
been substantiated by another report in 2013 (Röhrich et al., 2013) in addition to a report on 
biological active volatile compounds (Wickel et al., 2013). No new data were retrieved concerning the 
production of other classes of biological active metabolites or lack of such production. The body of 
knowledge remains limited and this species cannot be proposed for the QPS list.  
7.18. Verticillium albo-atrum  
Non-pathogenic strains of Verticillium albo-atrum are used as biocontrol agent to prevent Dutch elm 
disease by inducing the treated tree’s natural defence mechanisms.  Using Verticillium albo-atrum as 
keyword leads to the identification of 38 publications published during 2012 and the five first months 
of 2013, identified through a literature search. Pathogenicity of this fungal species in relation to Wilt 
diseases of vegetable crops was the focus of main part of these 38 reports. In 2013, EFSA published 
the ‘conclusion on the peer review of the pesticide risk assessment of the active substance 
Verticillium albo-atrum (strain WCS850)’ (EFSA, 2013n). 
Despite the apparent safe use as biocontrol agents of non-pathogenic isolates of Verticillium albo-
atrum, it has not been possible through extensive literature searches to verify a general absence of 
biological active secondary metabolites from this species. Verticillium albo-atrum remains ineligible 
for QPS status in 2013. 
7.19. Conclusions on filamentous fungi 
 The literature search that has been performed to establish this 2013 QPS opinion supports the 
conclusion of the previous review (EFSA, 2012a):   
(i)   the fungal taxonomy is in a rapid development as many phylogenetic studies are conducted 
and disclose new taxonomic units (i.e. phylogenetic species) leaving long-term recognized 
species with more narrow and clear boundaries. It has to be stressed that these studies seldom 
provides new information about the ecological properties and the function of the taxonomic 
units, which will be a major task in the future. The discontinuation of dual nomenclature for 
pleomorphic fungi will without any doubt require close attention in the years to come. The 
expected lists of recommended names to be used may result in nomenclatural changes to well-
established fungal species. This issue needs to be dealt with in future QPS updates. 
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(ii)  the increasing availability of fungal genome sequences could facilitate the discovery and 
characterization of numerous novel secondary metabolites by genome mining. Biosynthetic 
potential of numerous fungal strains will be successfully elucidated in a near future. While 
knowledge of fungal secondary metabolites accumulates exponentially, information on their 
toxic effects in humans and animals evolve at a much slower rate.  
8. Oomycetes 
8.1. Pythium oligandrum  
Pythium oligandrum is a non-pathogenic soil oomycete that colonizes the root ecosystem of many 
crops and has the ability to protect plants from biotic stress in addition to promoting plant growth. 
This promising biocontrol agent was the subject of 25 publications published during 2012 and the five 
first months of 2013, identified through a PubMed and Web of knowledge search. The most recent 
advances concerning the mechanisms by which Pythium oligandrum can exert its efficient 
mycoparasitic activity were gathered in the review of Benhamou et al. (2012). In 2013, EFSA 
published the conclusion on the peer review of the pesticide risk assessment of the active substance 
Pythium oligandrum strain M1 (EFSA, 2013o). To determine whether Pythium oligandrum produces 
toxic secondary metabolites was one of the data gaps identified in this last report.   
The literature review did not reveal any new information and because of a lacking body of knowledge 
this species remains ineligible for QPS status.  
9. Viruses used for plant protection  
9.1. Plant viruses  
Viruses belonging to certain plant virus families are sometimes used for cross protection purposes, i.e. 
the application of mild strains of a plant virus is used to protect the food or feed crop against strains 
of the virus giving severe symptoms. The potential effects of such viruses on animals and/or humans, 
when applied to food or feed, were reviewed and assessed, and the results were published in the 
EFSA Opinions on QPS in 2009 (EFSA, 2009b), 2010 (EFSA, 2010), 2011 (EFSA, 2011a) and 2012 
(EFSA, 2012a). Plant viruses do not replicate in organisms other than plants. The parts exposed to 
animal and/or humans are the coat protein(s) and the nucleic acid, in all but a few cases RNA. 
9.1.1. Alphaflexiviridae  
No scientific or other evidence was found that alphaflexiviruses (Family Alphaflexiviridae) or 
members thereof such as from the genus Potexvirus (Adams et al., 2011) have any negative effect on 
animals and humans to date. Viruses of this family have been reported from a wide range of 
herbaceous and woody plants, both mono-and dicotyledons. Species of this virus family are mostly 
plant-specific and are transmitted either mechanically or through insect vectors from plant to plant. In 
terms of safety, the familiarity principle was taken into account as well, in that these viruses have 
been part of the food and feed of animals and humans since plant material was part of the food 
package. The major component of an alphaflex virus (e.g. Pepino mosaic virus), the coat protein, is 
tested computationally in 2013 against a plant database (UniRef100 plant database (UniProt NREF, 
2013) and did not show any homology to known toxins. None of the hits were related to the search 
terms ‘disease’ or ‘toxins’. No other negative impacts of alphaflexiviruses, more specifically 
potexviruses such as Pepino Mosaic Virus (Genus Potexvirus) on humans or animals have been 
reported to date. Hence it was agreed that the family Alphaflexiviridae, as the highest taxonomic unit, 
is recommended for the QPS list. 
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Other relevant information   
For other plant virus families interactions of some viruses with humans have been reported (Colson et 
al., 2010; Liu et al., 2013). For example, pepper mild mottle virus (PMMoV), a member of the 
Tobamoviridae family, is present in stools from healthy individuals, but it is found associated with 
higher frequency in individuals with clinical symptoms (Colson et al., 2010). Such patients appear to 
have a higher specific immune response to PMMoV (seropositivity). Recently, Liu et al. (2013) 
argued that antibodies against Tobacco Mosaic Virus (TMV, Virgaviridae) in humans, e.g. as a long-
term consequence of smoking, interact with the human TOMM40L protein through a conserved 
amino acid stretch between TMV and TOMM40L. Such TMV antibodies are implied in the 
emergence of autoimmune diseases. However, a direct causal relationship between a plant virus and 
disease in humans, such as virus replication in cells or pathology has not been demonstrated. 
9.1.2. Potyviridae  
There was no scientific or other evidence that potyviruses (Family Potyviridae) or members thereof 
have any negative effect on animals and humans to date. In addition, the familiarity principle was 
taken into consideration as well in that these viruses have been part of the food and feed of animals 
and humans since plant material was part of the food package. By computational analysis it was 
further found that the major component of a potyvirus (Zucchini yellow mosaic virus), the coat 
protein, did not show any homology to known toxins (Kuiper et al., 2001; Health Canada, 1999). Such 
an analysis was repeated in 2012 against a plant database (UniRef100 plant database (UniProt NREF, 
2013)) and a general database (GenBank nt database, 2013) and none of the hits were related to 
‘disease’ or ‘toxic’. Since the last major review by Kuiper et al. (2001), no new information has 
appeared which would compromise the conclusion drawn in 2012. No other negative impacts of 
potyviruses on humans or animals have been reported to date. Hence it was agreed that the family 
Potyviridae, as the highest taxonomic unit, is recommended for the QPS list. 
9.2. Insect viruses 
9.2.1. Baculoviridae  
Viruses belonging to the family Baculoviridae and their potential effects on animals and humans, 
when applied to food or feed, were extensively reviewed and the results were published in the EFSA 
Opinion on QPS 2009 (EFSA, 2009b), 2010 (EFSA 2010), 2011 (EFSA 2011a) and 2012 (EFSA 
2012a). It was concluded that there was no scientific or other evidence that baculoviruses to date have 
any negative effect on animals and humans when used appropriately. In addition the familiarity 
principle was taken into consideration as well, in that these viruses have been extensively used for 
over six decades as biocontrol agents of insect pests without any report describing a negative effect on 
humans or animals. The OECD already concluded in 2002 that baculoviruses were safe to use for 
products meant for human consumption (OECD, 2002). Baculoviruses were also classified as Risk 
Group 1 (RG1) agents, as they were not related to any disease of humans (Flemming and Hunt, 2000; 
Kost and Condreay, 2001). Hence it was agreed that the family Baculoviridae is the highest 
taxonomic unit that should receive a QPS recommendation in the registration process (EFSA 2009b, 
2010, 2011a, 2012a).  
Since the last major review, no new information, which would compromise the conclusion drawn in 
2009, 2010, 2011 and 2012 has appeared. Further support for the safety of baculoviruses is taken from 
the fact that a number of baculovirus-derived products (recombinant proteins) have been registered 
including a vaccine against flu in 2012 or reached the market, such as vaccines against cervical cancer 
of humans (Harper, 2009; Szarewski, 2010), porcine circovirus for animals (Fort et al., 2009) and 
immunotherapeutics for human prostate cancer (Kantoff et al., 2010). 
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A matter of contention could be the observation that the budded virus (BV) phenotype of 
baculoviruses, that is responsible for the systemic infection of insect larvae, is able to infect vertebrate 
including mammalian cells and tissues (Hofmann et al., 1995) to serve as a gene delivery vehicle for 
recombinant protein production and gene therapy. The safety issues related to this particular 
application are discussed in detail in the 2011 QPS report and elsewhere (EFSA, 2011a; Kost and 
Condreay, 2001).  
The QPS recommendation for the family Baculoviridae as the highest taxonomic unit was confirmed.  
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10. The 2013 updated list of QPS Status recommended biological agents in support of 
EFSA risk assessments  
Table 1:   The 2013 updated list of QPS Status recommended biological agents for safety risk 
assessments carried out by EFSA Scientific Panels and Units  
Gram-Positive Non-Sporulating Bacteria 
Species  Qualifications *   
Bifidobacterium 
adolescentis  
Bifidobacterium animalis 
Bifidobacterium bifidum  
Bifidobacterium breve 
Bifidobacterium longum  
Corynebacterium 
glutamicum**  
  QPS only apply when the 
species is used for amino 
acid production 
Lactobacillus acidophilus  
Lactobacillus amylolyticus  
Lactobacillus amylovorus  
Lactobacillus alimentarius  
Lactobacillus aviaries  
Lactobacillus brevis  
Lactobacillus buchneri  
Lactobacillus casei *** 
Lactobacillus cellobiosus 
Lactobacillus coryniformis 
Lactobacillus crispatus  
Lactobacillus curvatus  
Lactobacillus delbrueckii 
Lactobacillus farciminis  
Lactobacillus fermentum  
Lactobacillus gallinarum  
Lactobacillus gasseri  
Lactobacillus helveticus  
Lactobacillus hilgardii  
Lactobacillus johnsonii  
Lactobacillus 
kefiranofaciens  
Lactobacillus kefiri  
Lactobacillus mucosae  
Lactobacillus panis 
Lactobacillus collinoides 
Lactobacillus paracasei  
Lactobacillus 
paraplantarum  
Lactobacillus pentosus  
Lactobacillus plantarum  
Lactobacillus pontis  
Lactobacillus reuteri  
Lactobacillus 
rhamnosus  
Lactobacillus sakei  
Lactobacillus salivarius  
Lactobacillus 
sanfranciscensis  
 
Lactococcus lactis    
Leuconostoc citreum 
Leuconostoc 
pseudomesenteroides 
Leuconostoc lactis Leuconostoc 
mesenteroides 
 
 
Oenococcus oeni    
Pediococcus acidilactici Pediococcus dextrinicus Pediococcus 
pentosaceus 
 
Propionibacterium 
freudenreichii 
Propionibacterium 
acidipropionici 
  
Streptococcus 
thermophilus 
   
Bacillus 
Species  Qualifications*  
Bacillus 
amyloliquefaciens  
Bacillus atrophaeus  
Bacillus clausii  
Bacillus coagulans  
Bacillus fusiformis 
Bacillus lentus  
Bacillus licheniformis  
Bacillus megaterium  
Bacillus mojavensis 
Bacillus pumilus  
Bacillus subtilis  
Bacillus vallismortis  
 
Absence of toxigenic 
activity. 
Geobacillus 
stearothermophilus 
 
  Absence of toxigenic 
activity. 
Gram-Negative Bacteria    
Species    
Gluconobacter oxydans 
 
  QPS only apply when the 
species is used for vitamin 
production 
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Yeasts††
 
Species  Qualifications  
Debaryomyces hansenii    
Hanseniaspora uvarum    
Kluyveromyces lactis Kluyveromyces marxianus   
Komagataella pastoris 
Lindnera jadinii  
Ogataea angusta 
  QPS only apply when the 
species is used for enzyme 
production 
Saccharomyces 
bayanus**** 
Saccharomyces 
cerevisiae†**** 
Saccharomyces 
pastorianus****  
  
Schizosaccharomyces 
pombe 
   
Wickerhamomyces 
anomalus**** 
  QPS only apply when the 
species is used for enzyme 
production 
Xanthophyllomyces 
dendrorhous (imperfect 
form Phaffia rhodozyma)  
   
Virus    
Plant viruses    
Family    
Alphaflexiviridae Potyviridae   
Insect viruses    
Family    
Baculoviridae    
 
* Generic qualification for all QPS bacterial taxonomic units: the strains should not harbour any acquired antimicrobial 
resistance genes to clinically relevant antibiotics. 
**  Brevibacterium lactofermentum is a synonym of Corynebacterium glutamicum  
*** The previously described species ‘Lactobacillus zeae’ has been included in the species Lactobacillus casei 
**** Absence of resistance to antimycotics used for medical treatment of yeast infections in cases where viable cells are 
added to the food or feed chain. In the case of Saccharomyces cerevisiae this qualification applies for yeast strains 
able to grow above 37 °C.  
†  Saccharomyces cerevisiae, subtype boulardii is contraindicated for persons with fragile health, as well as for patients 
with a central venous catheter in place.   
††  Yeast synonyms commonly used in the feed/food industry: 
  Wickerhamomyces anomalus: synonym Hansenula anomala, Pichia anomola, Saccharomyces anomalus 
  Lindnera jadinii: synonyms Pichia jadinii, Hansenula jadinii, Torulopsis utilis 
  Saccharomyces cerevisiae synonym: Saccharomyces boulardii 
  Saccharomyces pastorianus: synonym Saccharomyces carlsbergensis 
   Komagataella pastoris: synonym Pichia pastori 
 Ogataea angusta: synonym Pichia angusta 
 Debaromyces hansenii: synonym Candida famata 
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CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
 
Answer to the terms of reference (ToR): 
 
ToR1.: Preparation of an update of the list of biological agents notified to EFSA Units and/or 
Scientific Panels such as Pesticides, FEEDAP and GMO for intentional use in feed and/or food or as 
sources of food and feed additives, enzymes and plant protection products for safety assessment.   
The list was updated with the notifications received where applicable by EFSA Panels and Units since 
the last review.  
 
ToR2.: Annual review of the list of biological agents recommended for the QPS list. Where 
appropriate new taxonomic units should be assessed for their suitability for an inclusion in the QPS 
list, and taxonomic units previously assessed should be reviewed where new information has become 
available. The information provided in the previous opinion should be updated where appropriate. 
All taxonomic units previously recommended for the QPS list were reviewed and confirmed. The 
notifications were assessed. Gluconobacter oxydans and Alphaflexiviridae were assessed for the first 
time and recommended for the QPS list. The information of the previous opinion was updated for the 
taxonomic units on the QPS list. 
 
ToR3.: Review of the qualifications for taxonomic units included in the QPS recommended list and in 
particular the qualification regarding antimicrobial resistance in taxonomic units recommended for the 
QPS list. 
The information of the previous opinion was updated and the qualifications were confirmed.  
 
ToR4.: Review and update of the body of knowledge for notified filamentous fungi and enterococci. 
The knowledge of filamentous fungi notified to EFSA was updated. Although numerous data, 
published since the 2012 QPS opinion, have contributed to partially fulfil gaps of knowledge, too 
many unknowns remain in 2013 to allow a filamentous fungus to be recommended for the QPS list.  
Enterococcus faecium is not recommended for the QPS list in spite of the recent scientific knowledge 
allowing a differentiation of pathogenic from non-pathogenic strains. This is of value for the 
FEEDAP Scientific Panel dealing with the strain specific notification, but it is too recent knowledge 
for a QPS recommendation, considering the recent information on the evolution of the epidemiology 
of Enterococcus infections in human.  
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RECOMMENDATIONS 
While recent findings do not warrant any reconsideration of the QPS status of lactic acid bacteria 
(LAB) and Bacillus species, further studies on both human and veterinary clinical isolates particularly 
from cases where there have been no predisposing factors, should be considered to find out any 
specific factors that might contribute to the pathogenicity.  
Regarding LAB, in particular for Lactococcus lactis further studies on both human and veterinary 
clinical isolates could be considered to find out any possible strain specific factors that might 
contribute to the pathogenicity. 
Increased information on the structure of the Enterococcus faecium population, mainly derived from 
genomic analyses, indicates that a distinction between pathogenic and non-pathogenic strains may be 
possible. Therefore, additional population analyses and infection studies addressing a comprehensive 
collection of isolates are recommended. 
More data on minimum inhibitory concentrations (MIC) for therapeutic antimicrobials and guidelines 
for the interpretation are needed for some bacteria (e.g. propionic acid bacteria, Corynebacterium) 
used for food and feed purposes. 
More information on the absence of resistance to antimycotics used for medical treatment of yeast 
infections in cases where viable cells are added to the food or feed chain is needed.  
Concerning filamentous fungi, the same recommendations as those issued from the 2012 QPS opinion 
remain valid. Progresses have to be achieved to attain three main objectives:  
(i)  the definition and use of standardized methods to allow a correct identification of fungal 
species  
(ii)  an accurate establishment of the metabolic profile for each considered species and an 
increased knowledge of the factors controlling the production of fungal toxic metabolites 
(iii)  an increased knowledge of the toxicological impact of fungal secondary metabolites.  
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Appendix A.  Microbial species from previous notifications and as notified to EFSA 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
 Bacteria    
FEEDAP Actinoplanes utahensis Production of 
acarbose 
EFSA-Q-2007-172 
The EFSA Journal (2008) 839, 1-40 
www.efsa.europa.eu/en/scdocs/scdoc/839.htm 
 
No body of knowledge, therefore not 
appropriate for QPS (EFSA, 2008). 
Full safety assessment was performed in 
FEEDAP Opinion. 
FEEDAP Actinomadura yumaensis Production of 
maduramicin 
ammonium 
EFSA-Q-2008-757 
The EFSA Journal (2011) 9(1):1954 
www.efsa.europa.eu/en/efsajournal/doc/1954.pdf 
EFSA-Q-2011-00059 
Actinomadura yumaensis produce antibiotics, 
are therefore inappropriate for QPS (EFSA 
opinion 2008) 
FEEDAP Alcaligenes acidovorans  
= Ralstonia sp. 
 
Biomass for 
animal feed 
EFSA-Q-2004-171 
The EFSA Journal (2005) 230, 1-6 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620784006.htm 
No body of knowledge, therefore not 
appropriate for QPS (EFSA, 2008). 
Full safety assessment was performed in 
FEEDAP Opinion. 
FEEDAP Bacillus amyloliquefaciens Feed additive EFSA-Q-2007-190 
The EFSA Journal (2008) 773, 1-13 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1211902039267.htm 
 
EFSA-Q-2009-00825  
EFSA Journal 2010;8(12):1918 [2 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/1918.htm 
 
EFSA-Q-2011-00389  
EFSA Journal 2013;11(1):3042 [11 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/304
2.htm 
 
EFSA-Q-2011-00965  
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention.  
 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 54 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Bacillus amyloliquefaciens Production of 
Enzyme 
EFSA-Q-2007-0020 (GMM) 
www.efsa.europa.eu/en/efsajournal/pub/1156.htm 
and related opinions: 
EFSA-Q-2007-112 
www.efsa.europa.eu/en/efsajournal/pub/1154.htm 
EFSA-Q-2009-00470 
www.efsa.europa.eu/en/efsajournal/pub/1949.htm 
 
Other applications 
EFSA-Q-2010-01295  
EFSA-Q-2010-01297  
EFSA-Q-2012-00411  
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention. 
Pesticides  Bacillus amyloliquefaciens 
subspecies plantarum 
strain D747 
Plant protection 
product 
EFSA-Q-2013-00038  Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention. 
FEEDAP Bacillus brevis  
= Aneurinibacillus and Brevibacillus 
species 
Strains from B. brevis are now mostly 
Brevibacillus species and some are 
Aneurinibacillus species  
Biomass for 
animal feed 
EFSA-Q-2004-171 
The EFSA Journal (2005) 230, 1-6 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620784006.htm 
 
No sufficient body of knowledge and safety 
concern because of antibiotic production. 
Therefore not appropriate for QPS (EFSA, 
2008). It will no longer be assessed for the QPS 
list unless new notification to EFSA (2010). 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Bacillus cereus var. toyoi 
= B. cereus 
 
Feed additive EFSA-Q-2003-086 
The EFSA Journal (2004) 62, 1-5 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783486.htm 
 
EFSA-Q-2005-021 
The EFSA Journal (2005) 288, 1-7 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783657.htm 
 
EFSA-Q-2006-037 
The EFSA Journal (2007) 458, 1-9 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620781828.htm 
 
EFSA-Q-2007-090 
The EFSA Journal (2008) 549, 1-11 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178647331659.htm 
 
EFSA-Q-2008-287 
The EFSA Journal (2008) 913, 1-13 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1211902299515.htm 
 
EFSA-Q-2010-01095 and EFSA-Q-2011-00832  
EFSA Journal 2013;11(1):3042 [11 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/304
2.htm 
QPS status inapplicable for the group of B. 
cereus strains (see EFSA opinion 2007, 
Appendix B, EFSA, 2008). There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
 
Publication by Jiménez et al. (2013) on the 
description of Bacillus toyonensis sp. nov., as a 
novel species of Bacillus cereus (Syst. Appl. 
Microbiol., 36, 383-391) 
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Bacillus coagulans Feed additive  Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention.  
FEEDAP Bacillus firmus = Brevibacillus agri Biomass for 
animal feed 
EFSA-Q-2004-171 
The EFSA Journal (2005) 230, 1-6 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620784006.htm 
No body of knowledge, therefore not 
appropriate for QPS (EFSA 2008). It will no 
longer be assessed for the QPS list unless new 
notification to EFSA (EFSA, 2010). 
Pesticides Bacillus firmus I-1582 Plant protection 
product 
EFSA-Q-2011-00999  
EFSA Journal 2012;10(10):2868. [33 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2868.htm 
EFSA-Q-2013-00346 
A reassessed of this species was carried out in 
the QPS 2012 review and it was not 
recommended for the QPS list. 
FEEDAP Bacillus lentus Feed additive  Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention.  
FEEDAP Bacillus lentus Production of 
Enzyme 
EFSA-Q-2006-004: 
The EFSA Journal (2006) 412, 1-12 
www.efsa.europa.eu/en/efsajournal/pub/412.htm 
and related question: 
EFSA-Q-2012-00244 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention. 
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
European 
Commission 
SCF Opinion 
2000 
Bacillus licheniformis Production of b-
cyclodextrin 
(food additive 
carrier and 
stabiliser of 
food flavours, 
food colours and 
some vitamins) 
Scientific Committee on Food SCF/CS/ADD/AMI 
52 Final (13 July) 
Opinion of the Scientific Committee on Food 
On ß-cyclodextrin produced using cycloglycosyl-
transferase from a recombinant Bacillus 
licheniformis (adopted on 22 June 2000) 
http://ec.europa.eu/food/fs/sc/scf/out58_en.pdf 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention (2008, 2009, 2010, 2011, 2012, 
2013).  
FEEDAP Bacillus licheniformis Production of 
Enzyme 
EFSA-Q-2005-090 
The EFSA Journal (2006) 351, 1-11 
www.efsa.europa.eu/en/efsajournal/pub/351.htm 
EFSA-Q_2006-0181 
The EFSA Journal (2007) 451, 1-6 
www.efsa.europa.eu/en/efsajournal/pub/451.htm 
 
EFSA-Q-2010-00139  
EFSA Journal 2012;10(7):2777 [14 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/277
7.htm 
 
EFSA-Q-2008-431  
The EFSA Journal (2009) 1185, 1-15 
www.efsa.europa.eu/en/efsajournal/pub/1185.htm 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention. 
FEEDAP Bacillus licheniformis  Feed additive EFSA-Q-2006-136  
EFSA Journal 2011;9(9):2356 [10 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/2356.htm 
 
EFSA-Q-2007-166 (withdrawn) 
EFSA-Q-2009-00970 (withdrawn) 
EFSA-Q-2009-00680  
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention.  
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FIP Bacillus licheniformis 
strain NZYM-KE  
 
Production of 
food enzyme 
EFSA-Q-2012-00898 
The food enzyme is an alpha-amylase 
Qualification: Absence of toxigenic potential 
(see EFSA opinions, 2008, 2009, 2010, 2011, 
2012, 2013). The possibility that new virulence 
factors, with activities different from those 
described previously could be discovered should 
be kept under attention.  
FIP Bacillus licheniformis  
strain NZYM-AC 
Production of 
enzyme 
EFSA-Q-2013-00586 
The food enzyme is an alpha-amylase 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention.  
FIP Bacillus licheniformis  
strain NZYM-BC 
Production of 
enzyme 
EFSA-Q-2013-00685 
The food enzyme is an alpha-amylase 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention. 
FEEDAP Bacillus megaterium Production of 
vitamin C 
 
EFSA-Q-2010-01290 amended EFSA-Q-number: 
EFSA-Q-2011-00250 
EFSA Journal 2013;11(2):3103 [25 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/310
3.htm 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention.  
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Bacillus pumilus Feed additive  Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention.  
Pesticides  Bacillus pumilus 
strain QST 2808 
Plant protection 
product 
EFSA-Q-2012-00776  
EFSA Journal 2013;11(8):3346, 31 pp. 
www.efsa.europa.eu/en/efsajournal/pub/3346.htm 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention. 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Bacillus subtilis Feed additive EFSA-2003-008 
www.efsa.europa.eu/en/efsajournal/pub/6.htm 
 
EFSA-Q-2004-174 
www.efsa.europa.eu/en/efsajournal/pub/272.htm 
 
EFSA-Q-2005-150  
www.efsa.europa.eu/en/scdocs/scdoc/336.htm 
 
EFSA-Q-2005-237  
The EFSA Journal (2006) 336, 1-15 
www.efsa.europa.eu/en/scdocs/scdoc/406.htm 
 
EFSA-Q-2006-136  
EFSA Journal 2011;9(9):2356 [10 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/2356.htm 
 
EFSA-Q-2007-166 (withdrawn) 
 
EFSA-Q-2007-040  
The EFSA Journal (2007) 543, 1-8 
www.efsa.europa.eu/en/scdocs/scdoc/543.htm 
 
EFSA-Q-2008-473  
EFSA Journal 2009; 7(9):1314 
www.efsa.europa.eu/en/scdocs/scdoc/1314.htm 
 
EFSA-2008-771 
www.efsa.europa.eu/en/efsajournal/pub/2375.htm   
 
EFSA-Q-2009-00533  
EFSA Journal 2010; 8(1):1426 
www.efsa.europa.eu/en/scdocs/scdoc/1426.htm 
 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention.  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Bacillus subtilis Feed additive EFSA-Q-2009-00680  
EFSA-Q-2009-00525  
 
EFSA-Q-2010-00814 
EFSA Journal 2010;8(10):1867 
www.efsa.europa.eu/en/scdocs/scdoc/1867.htm 
 
EFSA-Q-2010-001151 
EFSA Journal 2011;9(3):2112 
www.efsa.europa.eu/en/efsajournal/pub/2112.htm 
 
EFSA-Q-2010-01150 
EFSA Journal 2011;9(3):2114  
www.efsa.europa.eu/en/efsajournal/pub/2114.htm 
 
EFSA-Q-2011-01151  
EFSA Journal 2013;11(4):3176 [9 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/317
6.htm 
 
EFSA-Q-2012-00246 
EFSA Journal 2012;10(5):2671 [8 pp.].  
http://www.efsa.europa.eu/en/efsajournal/pub/267
1.htm  
 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention. 
FEEDAP Bacillus subtilis  
 
Production of 
vitamin B2 
EFSA-Q-2010-00991  
EFSA-Q-2010-01319  
EFSA-Q-2012-00954 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention. 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 62 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP  Bacillus subtilis  
 
Production of 
enzyme 
EFSA-Q-2012-00411 
 
EFSA-Q-2007-0020 
The EFSA Journal (2009) 1156, 1-25 
www.efsa.europa.eu/en/efsajournal/pub/1156.htm 
and related opinions: 
 
EFSA-Q-2007-112 
The EFSA Journal (2009) 1154, 1-11 
www.efsa.europa.eu/en/efsajournal/pub/1154.htm 
 
EFSA-Q-2009-00470: 
www.efsa.europa.eu/en/efsajournal/pub/1949.htm 
 
Other applications: 
EFSA-2010-Q-01298  
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention. 
Pesticides Bacillus subtilis 
Strain QST 713 
Plant protection 
product 
EFSA-Q-2008-492  
Review report for the active substance Bacillus 
subtilis QST 713, SANCO/10184/2003-final, July 
2006 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention.  
FIP Bacillus subtilis 
strain MAM 
Production of 
enzyme 
EFSA-Q-2013-00790 
The food enzyme is a glucan 1,4-α-
maltohydrolase 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010, 2011, 2012, 2013). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention. 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
Pesticides Bacillus subsp. thuringiensis aizawai 
 (strains ABTS 1857 and GC-91) 
= Bacillus thuringiensis serovar 
aizawai 
 
Plant protection 
product 
EFSA-Q-2009-00121  
EFSA-Q-2009-00247  
EFSA Journal 2013;11(1):3063. [49 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/3063.htm 
 
 
Already considered as not appropriate for QPS 
(see EFSA opinion, 2007). There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
Pesticides Bacillus subsp. thuringiensis 
israelensis  
(serotype H-14), strain AM 6552 
= Bacillus thuringiensis serovar 
israelensis 
Plant protection 
product 
EFSA-Q-2009-00122  
EFSA-Q-2009-00248  
EFSA Journal 2013;11(1):3054 
www.efsa.europa.eu/it/efsajournal/pub/3054.htm 
Already considered as not appropriate for QPS 
(see EFSA, 2007). There is increasing evidence 
of pathogenicity, and this species will not longer 
be assessed unless new scientific information 
becomes available. 
Pesticides Bacillus subsp. thuringiensis kurstaki  
(strains ABTS 351, PB 54, SA11, SA 
12, EG 2348) 
= Bacillus thuringiensis serovar 
kurstaki 
Plant protection 
product 
EFSA-Q-2009-00123  
EFSA-Q-2009-00249  
EFSA Journal 2012;10(2):2540. [66 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2540.htm 
 
Already considered as not appropriate for QPS 
(see EFSA, 2007). There is increasing evidence 
of pathogenicity, and this species will not longer 
be assessed unless new scientific information 
becomes available. 
Pesticides Bacillus subsp. thuringiensis 
tenebrionis  
(strain NB176 (TM 141)) 
= Bacillus thuringiensis serovar 
tenebrionis 
Plant protection 
product 
EFSA-Q-2009-00124  
EFSA-Q-2009-00250  
EFSA Journal 2013;11(1):3024. [36 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/3024.htm 
Already considered as not appropriate for QPS 
(see EFSA, 2007). There is increasing evidence 
of pathogenicity, and this species will not longer 
be assessed unless new scientific information 
becomes available. 
FEEDAP Bifidobacterium animalis  Feed additive EFSA-Q-2006-169 (withdrawn) 
 
EFSA-Q-2009-00823  
EFSA Journal 2012;10(12):2965 [2 pp.].  
http://www.efsa.europa.eu/en/efsajournal/pub/296
5.htm 
 
EFSA-Q-2009-00817  
EFSA Journal 2012;10(12):2964 [14 pp.].  
http://www.efsa.europa.eu/en/efsajournal/pub/296
4.htm 
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Bifidobacterium longum Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
GMO Brevibacterium lactofermentum 
=Corynebacterium glutamicum 
 
Dried killed 
biomass for feed 
EFSA-Q-2007-157  
(Applicant is going to withdraw application) 
The recipient species is QPS for production 
purposes only, but not for this application, 
therefore not appropriate for QPS 
(EFSA, 2008 opinion) 
FIP (CEF 
Panel) 
Carnobacterium maltaromaticum 
CNCM I-3298 
Microbiological 
time 
temperature 
integrators used  
as ‘active and 
intelligent’  food 
contact 
materials 
EFSA-Q-2011-00120  No QPS recommendation given because the 
species represents fish pathogens (EFSA, 2012) 
FEEDAP 
 
 
 
Clostridium butyricum Feed additive EFSA-Q-2008-303 
The EFSA Journal (2009) 1039, 1-6 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1211902496474.htm 
 
EFSA-Q-2010-00140 
EFSA Journal 2011;9(1):1951 [15 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/1951.htm 
No history of use, possible production of 
botulinum toxins, therefore not appropriate for 
QPS (EFSA, 2008) 
FEEDAP Corynebacterium glutamicum Production of L-
arginin 
EFSA-Q-2006-031 
The EFSA Journal (2007) 473, 1-19 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620781637.htm 
QPS status applies only when the species is used 
for production purposes (EFSA opinion, 2007) 
FEEDAP Corynebacterium glutamicum Production of L-
lysine sulphate 
EFSA-Q-2011-00996  
 
QPS status applies only when the species is used 
for production purposes (EFSA opinion, 2007) 
FEEDAP Corynebacterium glutamicum 
(Brevibacterium flavum) 
 
Production of L-
lysine HCl or 
sulphate 
EFSA-Q-2011-00991  
 
 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Corynebacterium pekinese  
= Corynebacterium glutamicum 
Production of L-
lysine sulphate 
EFSA-Q-2011-00995  
 
Corynebacterium pekinese is not a valid species 
name however used in the literature 
[www.ncbi.nlm.nih.gov/pubmed/?term=coryneb
acterium+pekinense e.g. Ma W, Zhao Z, Wang 
Y, Zhang Y, Ding J. Wei Sheng Wu Xue Bao. 
2012 Nov 4;52(11):1344-51. Chinese] 
FEEDAP Corynebacterium glutamicum Production of L-
tryptophan 
EFSA-Q-2011-00946  QPS status applies only when the species is used 
for production purposes (EFSA opinion, 2007) 
FEEDAP Corynebacterium glutamicum Production of L-
valine 
EFSA-Q-2012-00377  QPS status applies only when the species is used 
for production purposes (EFSA opinion, 2007) 
FEDDAP Ensifer adhaerens  
 
Production of 
vitamin B12 
EFSA-Q-2012-00455 
EFSA-Q-2012-00456 
Not recommended for the QPS list, QPS 2011 
update due to insufficient body of knowledge 
FEEDAP Ensifer fredii 
 
Production of 
vitamin B12 
EFSA-Q-2012-00456 Not recommended for the QPS list, QPS 2011 
update due to insufficient body of knowledge 
FEEDAP Enterococcus faecium Feed additive EFSA-Q-2003-087 
The EFSA Journal (2005) 207, 1-6 
www.efsa.europa.eu/en/scdocs/scdoc/207.htm 
 
EFSA-Q-2004-001  
The EFSA Journal (2004) 51, 1-6 
www.efsa.europa.eu/en/scdocs/scdoc/51.htm 
 
EFSA-Q-2004-006 
The EFSA Journal (2004) 138, 1-7 
www.efsa.europa.eu/en/efsajournal/pub/138.htm 
 
EFSA-Q-2004-027 
The EFSA Journal (2004) 120, 1-4 
www.efsa.europa.eu/en/scdocs/scdoc/120.htm 
 
EFSA-Q-2004-096 
The EFSA Journal (2005) 206, 1-6 
www.efsa.europa.eu/en/scdocs/scdoc/206.htm 
No taxonomical unit within Enterococcus can be 
considered as free of infectious strains. 
Therefore no recommendation for QPS status 
(EFSA, 2007, 2008, 2009, 2010, 2011, 2012). 
There is increasing evidence of pathogenicity, 
and this species will not longer be assessed 
unless new scientific information becomes 
available (2010). 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
 
EFSA-Q-2005-020  
The EFSA Journal (2006) 335, 1-10 
www.efsa.europa.eu/en/scdocs/scdoc/335.htm 
 
EFSA-Q-2006-061 
The EFSA Journal (2007) 440, 1-9 
www.efsa.europa.eu/en/scdocs/scdoc/440.htm 
 
EFSA-Q-2006-318  
EFSA Journal 2009; 7(11):1379 
www.efsa.europa.eu/en/scdocs/scdoc/1379.htm 
 
EFSA-Q-2006-135  
The EFSA Journal (2008) 912, 1-13 
www.efsa.europa.eu/en/scdocs/scdoc/912.htm 
 
EFSA-Q-2006-169 (withdrawn)   
 
EFSA-Q-2006-135 
The EFSA Journal (2008) 912, 1-13 
www.efsa.europa.eu/en/efsajournal/pub/912.htm 
 
EFSA-Q-2007-033  
The EFSA Journal (2007) 521, 1-8 
www.efsa.europa.eu/en/scdocs/scdoc/521.htm 
 
EFSA-Q-2008-289 
The EFSA Journal (2009) 990, 1-12 
www.efsa.europa.eu/en/scdocs/scdoc/990.htm 
 
EFSA-Q-2008-471 (withdrawn) 
 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
EFSA-Q-2008-422 
EFSA Journal 2010; 8(7):1661 [13 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/1661.htm 
 
EFSA-Q-2009-00679  
EFSA Journal 2012;10(2):2574 [15 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/257
4.htm 
 
EFSA-Q-2009-00969  
EFSA Journal 2011;9(3):2118 
www.efsa.europa.eu/en/efsajournal/pub/2118.htm 
 
EFSA-Q-2009-00823  
EFSA Journal 2012;10(12):2965 
http://www.efsa.europa.eu/en/efsajournal/doc/296
5.pdf 
 
EFSA-Q-2009-00202 (withdrawn) 
 
EFSA-Q-2010-00070 
EFSA Journal 2010; 8(6): 1636 [5 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/1636.htm 
 
EFSA-Q-2012-00093 
EFSA Journal 2013;11(1):3044 [11 pp.].  
http://www.efsa.europa.eu/en/efsajournal/pub/304
4.htm 
 
EFSA-Q-2010-00009  
EFSA Journal 2013;11(2):3097 [14 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/309
7.htm  
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
EFSA-Q-2010-00071  
EFSA Journal 2013;11(4):3170 [13 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/317
0.htm 
 
EFSA-Q-2011-00203  
EFSA Journal 2013;11(4):3170 [13 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/317
0.htm 
 
EFSA-Q-2012-00093  
EFSA Journal 2013;11(1):3044 [11 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/304
4.htm 
 
EFSA-Q-2012-00421 
EFSA Journal 2013;11(4):3175 [14 pp.].  
http://www.efsa.europa.eu/en/efsajournal/pub/317
5.htm 
 
EFSA-Q-2012-00420 
EFSA Journal 2013;11(2):3098 [15 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/309
8.htm 
 
EFSA-Q-2012-00080  
EFSA Journal 2013;11(10):3363 [22 pp.]. 
http://www.efsa.europa.eu/fr/efsajournal/doc/3363
.pdf 
 
EFSA-Q-2011-00965  
EFSA-Q-2012-00245  
  
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 69 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
EFSA-Q-2012-00454 
EFSA-Q-2012-00419 
EFSA-Q-2012-00422 
 
FEEDAP Enterococcus mundtii Feed additive  No taxonomical unit within Enterococcus can be 
considered as free of infectious strains. 
Therefore no recommendation for QPS status 
(EFSA opinion, 2007) 
GMO Escherichia coli Dried killed 
biomasses for 
feed 
EFSA-Q-2008-412a and EFSA-Q-2008-669a 
 
QPS 2009, 2010 update. There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
FEEDAP Escherichia coli Dried killed 
biomasses for 
feed 
 
EFSA-Q-2008-412b and EFSA-Q-2008-669b 
 
QPS 2009, 2010 updates. There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
FEEDAP Escherichia coli Feed additive L-
lysine 
production 
EFSA-Q-2011-00992  
EFSA Journal 2013;11(10):3365 [3 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/336
5.htm 
EFSA-Q-2011-00993  
EFSA Journal 2013;11(10):3365 [3 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/336
5.htm 
EFSA-Q-2011-00994  
EFSA Journal 2013;11(10):3365 [3 pp.].  
http://www.efsa.europa.eu/en/efsajournal/pub/336
5.htm 
EFSA-Q-2011-00995  
EFSA-Q-2011-00996  
 
QPS 2009, 2010 updates. There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Escherichia coli Feed additive L-
threonine 
production 
EFSA-Q-2012-00113  
EFSA-Q-2012-00114  
EFSA-Q-2012-00115  
EFSA-Q-2012-00116  
EFSA-Q-2012-00117  
EFSA-Q-2012-00118  
 
QPS 2009, 2010 updates. There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
FEEDAP Escherichia coli Feed additive L-
threonine 
production 
EFSA-Q-2012-00113 Is not recommended for the QPS list in the past. 
There is increasing evidence of pathogenicity 
(QPS 2009, 2010). 
FEEDAP Escherichia coli Feed additive L-
tryptophan 
production 
EFSA-Q-2011-00946  
EFSA-Q-2011-00947  
EFSA Journal 2013;11(10):3368 [2 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/336
8.htm 
EFSA-Q-2011-00948  
EFSA-Q-2011-00949  
QPS 2009, 2010 updates. There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
FEEDAP Escherichia coli Feed additive  
(horses) 
EFSA-Q-2005-167 
The EFSA Journal (2009) 989, 1-14 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1211902391773.htm 
QPS 2009, 2010 updates. There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
FIP Escherichia coli   To produce 
polyhydroxyalka
noate (PHA) = 
from the 
reaction of 
dextrose and 1,4 
butanediol  
EFSA-Q-2011-01080 Additionnal data requested, expected in June 
2013 
QPS 2009, 2010 updates. There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Eubacterium sp. 
 
 
Reduce toxicity 
of mycotoxins 
EFSA-Q-2003-052 
The EFSA Journal (2005) 169, 1-14 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620782757.htm 
EFSA Journal (2013) 11(5):3203 
http://www.efsa.europa.eu/en/efsajournal/pub/320
3.htm 
No body of knowledge. Already given a 
negative assessment by FEEDAP. Not 
appropriate for QPS (EFSA opinion 2008). 
FEEDAP BIOMIN
®
 BBSH 797 - DSM 11798 
Genus nov. (formerly Eubacterium) 
species nov 
 
Feed additive EFSA-Q-2012-00719 
EFSA Journal 2013;11(5):3203 [18 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/320
3.htm 
Most likely a Coriobacterium species. Seems to 
be a new species without any body of 
knowledge. 
FEEDAP Gluconobacter oxydans Production of 
vitamin C 
EFSA-Q-2011-00250 
EFSA Journal 2013;11(2):3102 
http://www.efsa.europa.eu/en/efsajournal/pub/310
3.htm 
New species to be assessed for QPS 2013 
update 
FEEDAP Ketogulonicigenium vulgare Production of 
vitamin C 
 
EFSA-Q-2011-00250  
EFSA Journal 2013;11(2):3102 
http://www.efsa.europa.eu/en/efsajournal/pub/310
3.htm 
Not recommended for the QPS list, QPS 2011 
update due to insufficient body of knowledge 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 72 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Lactobacillus acidophilus Feed additive EFSA-Q-2003-115  
The EFSA Journal (2004) 119, 1-7 
www.efsa.europa.eu/en/scdocs/scdoc/119.htm 
 
EFSA-Q-2003-055  
The EFSA Journal (2004) 52, 1-7 
www.efsa.europa.eu/en/scdocs/scdoc/52.htm 
 
EFSA-Q-2006-135 
The EFSA Journal (2008) 912, 1-13 
www.efsa.europa.eu/en/scdocs/scdoc/912.htm 
 
EFSA-Q-2008-377 (withdrawn) 
 
EFSA-Q-2010-00071  
EFSA Journal 2013;11(4):3170 [13 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/317
0.htm 
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacillus amylolyticus Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacillus amylovorans Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Lactobacillus brevis Feed additive EFSA-Q-2010-01304  
EFSA Journal 2012;10(3):2617 [11 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/261
7.htm 
 
EFSA-Q-2011-00382  
EFSA Journal 2013;11(4):3168 [16 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/316
8.htm 
 
EFSA-Q-2011-00385  
EFSA Journal 2011;9(9):2368  
www.efsa.europa.eu/en/efsajournal/pub/2368.htm 
 
EFSA-Q-2012-00086  
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacilllus buchneri Feed additive EFSA-Q-2010-01276 
EFSA Journal 2011;9(4):2138  
www.efsa.europa.eu/en/efsajournal/pub/2138.htm  
 
EFSA-Q-2011-00375  
EFSA Journal 2011;9(9):2359  
www.efsa.europa.eu/en/efsajournal/pub/2359.htm  
 
EFSA-Q-2011-00376 
EFSA Journal 2011;9(9):2361 
www.efsa.europa.eu/en/efsajournal/pub/2361.htm 
 
EFSA-Q-2011-00382  
EFSA Journal 2013;11(4):3168 [16 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/316
8.htm 
 
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Lactobacillus bulgaricus 
 = L. delbrueckii subsp. bulgaricus 
Feed additive EFSA-Q-2006-135  
The EFSA Journal (2008) 912, 1-13 
www.efsa.europa.eu/en/scdocs/scdoc/912.htm 
 
EFSA-Q-2010-00071  
EFSA Journal 2013;11(4):3170 [13 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/317
0.htm 
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacillus casei (note: this species 
is very rare and its identity might 
need to be verified) 
Feed additive EFSA-Q-2011-00381 
EFSA Journal 2012;10(9):2884 [14 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/288
4.htm 
 
EFSA-Q-2011-00390  
EFSA Journal 2013;11(10):3362 [13 pp.].   
http://www.efsa.europa.eu/en/efsajournal/pub/336
2.htm 
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacillus casei rhamnosus 
= Lactobacillus rhamnosus 
Feed additive EFSA-Q-2011-00380  
EFSA Journal 2011;9(9):2365 
http://www.efsa.europa.eu/en/efsajournal/pub/236
5.htm  
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacillus cellobiosus Feed additive  Not initially considered for QPS (see EFSA 
opinions 2007, 2008). QPS recommended 2009, 
2010 
FEEDAP Lactobacillus collinoides Feed additive EFSA-Q-2012-00086  Not initially considered for QPS status (see 
EFSA opinions 2007, 2008). QPS recommended 
2009, 2010, 2011, 2012, 2013) 
FEEDAP Lactobacillus delbrueckii subsp. 
lactis 
Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Lactobacillus farciminis Feed additive EFSA-Q-2006-062 
The EFSA Journal (2008) 771, 1-13 
www.efsa.europa.eu/en/scdocs/scdoc/771.htm 
 
EFSA-Q-2004-177  
The EFSA Journal (2006) 377, 1-6 
www.efsa.europa.eu/en/scdocs/scdoc/377.htm 
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacillus fermentum Feed additive EFSA-Q-2012-00085  Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacillus helveticus Feed additive EFSA-Q-2006-135  
The EFSA Journal (2008) 912, 1-13 
www.efsa.europa.eu/en/scdocs/scdoc/912.htm 
 
EFSA-Q-2010-00071  
EFSA Journal 2013;11(4):3170 [13 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/317
0.htm 
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacillus mucosae Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacillus paracasei Feed additive EFSA-Q-2011-00378  
EFSA Journal 2011;9(9):2363 
www.efsa.europa.eu/en/efsajournal/pub/2363.htm 
 
EFSA-Q-2011-00387 (in progress) 
EFSA Journal 2011;9(9):2370 
http://www.efsa.europa.eu/en/efsajournal/pub/237
0.htm  
 
EFSA-Q-2012-00082   
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacillus pentosus 
 
Feed additive EFSA-Q-2011-00388  
EFSA Journal 2011;9(11):24 
www.efsa.europa.eu/en/efsajournal/pub/2449.htm  
 
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Lactobacillus plantarum Feed additive EFSA-Q-2010-01164  
EFSA Journal 2011;9(3):2113  
www.efsa.europa.eu/en/efsajournal/pub/2113.htm 
EFSA-Q-2011-00062  
EFSA Journal 2011;9(6):2275  
www.efsa.europa.eu/en/efsajournal/pub/2275.htm 
EFSA-Q-2011-00186  
EFSA Journal 2011;9(11):2408 
www.efsa.europa.eu/en/efsajournal/pub/2408.htm 
EFSA-Q-2011-00377  
EFSA Journal 2011;9(9):2362 
www.efsa.europa.eu/en/efsajournal/pub/2362.htm 
EFSA-Q-2011-00384  
EFSA Journal 2011;9(9):2367 
www.efsa.europa.eu/en/efsajournal/pub/2367.htm 
EFSA-Q-2011-00943 
EFSA Journal 2012;10(1):2529 
www.efsa.europa.eu/en/efsajournal/pub/2529.htm 
EFSA-Q-2011-00374  
EFSA Journal 2012;10(6):2732 [36 pp.].  
http://www.efsa.europa.eu/en/efsajournal/pub/273
2.htm 
EFSA-Q-2012-00089  
EFSA Journal 2012;10(7):2780 [15 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/278
0.htm 
EFSA-Q-2011-00390  
EFSA Journal 2013;11(10):3362 [13 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/336
2.htm 
EFSA-Q-2011-00944  
EFSA-Q-2011-00125  
 
 
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 77 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
    
EFSA-Q-2012-00083  
EFSA-Q-2012-00090  
EFSA-Q-2012-00092  
EFSA-Q-2012-00094  
 
FEEDAP Lactobacillus reuteri Feed additive EFSA-Q-2003-010 
The EFSA Journal (2005) 229, 1-7 
www.efsa.europa.eu/en/scdocs/scdoc/229.htm 
 
EFSA-Q-2006-169 (withdrawn) 
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacillus rhamnosus Feed additive EFSA-Q-2006-062 
The EFSA Journal (2008) 771, 1-13 
www.efsa.europa.eu/en/scdocs/scdoc/771.htm 
EFSA-Q-2011-00380 
EFSA Journal 2011;9(9):2365 
www.efsa.europa.eu/en/efsajournal/pub/2365.htm 
 
EFSA-Q-2011-00125  
 
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
Lactobacillus rhamnosus is recommended for 
the QPS list, and remains a topic for 
surveillance. 
FEEDAP Lactobacillus sakei Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Lactobacillus salivarius Feed additive EFSA-Q-2006-169 (withdrawn) 
 
EFSA-Q-2009-00823  
EFSA Journal 2012;10(12):2965 [2 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/296
5.htm 
 
EFSA-Q-2011-00381  
EFSA Journal 2012;10(9):2884 [14 pp.].  
http://www.efsa.europa.eu/en/efsajournal/pub/288
4.htm  
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Lactococcus lactis  Feed additive EFSA-Q-2006-135 
www.efsa.europa.eu/en/efsajournal/pub/912.htm 
 
EFSA-Q-2010-00901  
EFSA Journal 2011;9(9):2374 
www.efsa.europa.eu/en/efsajournal/pub/2374.htm 
 
EFSA-Q-2011-00373  
EFSA Journal 2011;9(12):2448 
www.efsa.europa.eu/en/efsajournal/pub/2448.htm 
 
EFSA-Q-2011-00383  
EFSA Journal 2011;9(9):2366 
www.efsa.europa.eu/en/efsajournal/pub/2366.htm 
 
EFSA-Q-2010-00071 
EFSA Journal 2013;11(4):3170 [13 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/317
0.htm 
  
EFSA-Q-2012-00087  
 
Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
Attention should be focused on human clinical 
cases without underlying predisposing factors 
(EFSA, 2011). 
2001/122/EC Leuconostoc mesenteroides Production of 
dextran as NF 
ingredient for 
bakery industrial 
and food 
fermentations 
 Already QPS (EFSA, 2007, 2008, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Leuconostoc oeno = Oenococcus oeni Feed additive  Not initially considered for QPS (see EFSA 
opinion 2007, 2008) and  recommended for the 
QPS list in 2009, 2010, 2011, 2012, 2013  
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Leuconostoc pseudomesenteroides Feed additive  Not initially considered for QPS (see EFSA 
opinion 2007, 2008, 2009, 2010, 2011) and  
recommended for the QPS list in 2012 (EFSA 
opinion, 2012) and confirmed in 2013. 
FEEDAP Methylococcus capsulatus Biomass for 
animal feed 
EFSA-Q-2004-171 
The EFSA Journal (2005) 230, 1-6 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620784006.htm 
No body of knowledge, therefore not 
appropriate for QPS (EFSA, 2008) 
Opinion SCF 
adopted on 
22/06/2000 
Paenibacillus macerans b-cyclodextrin 
production 
(food additive) 
 QPS 2009 update not recommended for QPS 
because of insufficient body of knowledge. It 
will no longer be assessed for the QPS list 
unless new notification to EFSA. 
 
FEEDAP Astaxanthin-rich Paracoccus 
carotinifaciens 
Production of 
red carotenoids 
EFSA-Q-2006-173 
The EFSA Journal (2007) 546, 1-30 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178650355146.htm 
 
EFSA-Q-2009-00629 
EFSA Journal 2010; 8(1):1428 [8 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/1428.htm 
 
EFSA-Q-2012-00064 
No body of knowledge, therefore not considered 
for QPS (EFSA, 2008) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Pediococcus acidilactici Feed additive EFSA-Q-2006-169 (withdrawn) 
 
EFSA-Q-2007-205  
The EFSA Journal (2009) 1037, 1-13 
www.efsa.europa.eu/en/scdocs/scdoc/1037.htm 
 
EFSA-Q-2008-421 
The EFSA Journal (2009) 1038, 1-11 
www.efsa.europa.eu/en/scdocs/scdoc/1038.htm 
 
EFSA-2009-00719  
EFSA Journal 2010;8(7):1660 
www.efsa.europa.eu/en/scdocs/scdoc/1660.htm 
 
EFSA-2009-00716  
EFSA Journal 2010;8(10):1865 
www.efsa.europa.eu/en/scdocs/scdoc/1865.htm 
 
EFSA-2009-00719  
EFSA Journal 2010;8(7):1660 
www.efsa.europa.eu/en/scdocs/scdoc/1660.htm 
 
EFSA-2009-00716  
EFSA Journal 2010;8(10):1865 
www.efsa.europa.eu/en/scdocs/scdoc/1865.htm 
 
EFSA-Q-2011-00379  
EFSA Journal 2011;9(9):2364  
www.efsa.europa.eu/en/efsajournal/pub/2364.htm 
 
EFSA-Q-2011-00940  
EFSA Journal 2012;10(6):2733   
http://www.efsa.europa.eu/en/efsajournal/pub/273
3.htm 
Already QPS 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
   EFSA-Q-2011-00941  
EFSA-Q-2012-00084  
 
EFSA-Q-2012-00253  
EFSA Journal 2012;10(7):2776  
http://www.efsa.europa.eu/en/efsajournal/pub/277
6.htm 
 
 
FEEDAP Pediococcus pentosaceus Feed additive EFSA-Q-2009-00717 
EFSA Journal 2010; 8(2):1502 
www.efsa.europa.eu/en/scdocs/scdoc/1502.htm 
 
EFSA-Q-2011-00386   
EFSA Journal 2011;9(9):2369 
www.efsa.europa.eu/en/efsajournal/pub/2369.htm  
 
EFSA-Q-2011-00940   
EFSA Journal 2012;10(6):2733 [15 pp.].  
http://www.efsa.europa.eu/en/efsajournal/pub/273
3.htm 
 
EFSA-Q-2012-00091  
EFSA Journal 2013;11(7):3284 [2 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/328
4.htm 
 
EFSA-Q-2012-00081   
EFSA-Q-2012-00087  
 
Already QPS 
FEEDAP Propionibacterium acidipropionici Feed additive EFSA-Q-2011-00953  
EFSA Journal 2012;10(5):2673 [10 pp.].  
http://www.efsa.europa.eu/en/efsajournal/pub/267
3.htm 
Not proposed for QPS status (see EFSA opinion 
2007, Appendix A). In 2009, 2010 
recommended for the QPS list (EFSA, 2009, 
2010). 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Propionibacterium freudenreichii 
shermanii 
Feed additive  Already QPS 
FEEDAP Propionibacterium freudenreichii 
shermanii  
Production of 
vitamin B12 
EFSA-Q-2012-00456 
EFSA-Q-2012-00457 
Already QPS 
FEEDAP Propionibacterium globosum  
[=subspecies of Propionibacterium 
freudenreichii] 
Feed additive  Not recommended for QPS (see EFSA opinion 
2007, Appendix A). Identical with P. 
freudenreichii therefore included  on QPS 
(EFSA, 2010) 
Pesticides Pseudomonas sp. DSMZ 13134 Plant Protection 
Product 
EFSA-Q-2011-01198  
EFSA Journal 2012;10(12):2954. [32 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2954.htm 
 
 
Not assessed because species to be clarified 
(EFSA, 2009) 
Pesticides Pseudomonas chlororaphis strain 
MA342 
Plant Protection 
Product 
EFSA-Q-2008-618 
Review report for the active substance 
Pseudomonas chlororaphis, EU-SANCO, 
4204/VI/98-Final, March 2004 
 
Not recommended for QPS in QPS 2009 update 
because of insufficient body of knowledge and a 
potential risk linked to production of secondary 
metabolites. It will no longer be assessed for the 
QPS list unless new notification to EFSA. 
 
 
FEEDAP Rhodopseudomonas palustris Feed additive  Insufficient body of knowledge (EFSA 2009). It 
will no longer be assessed for the QPS list 
unless new notification to EFSA. 
 
FEEDAP Serratia rubidaea Feed additive  Insufficient body of knowledge (EFSA 2009). It 
will no longer be assessed for the QPS list 
unless new notification to EFSA. 
 
FEEDAP Streptococcus cremoris = L. lactis 
subsp. cremoris 
Feed additive  Already QPS 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Streptococcus faecium  
= Enterococcus faecium 
Feed additive  No taxonomical unit within Enterococcus can be 
considered as free of infectious strains. 
Therefore no recommendation for QPS status 
(EFSA opinions 2007, 2008, 2009, 2010).  
There is increasing evidence of pathogenicity, 
and this species will not longer be assessed 
unless new scientific information becomes 
available. 
FEEDAP Streptococcus thermophilus Feed additive EFSA-Q-2006-135  
www.efsa.europa.eu/en/scdocs/scdoc/912.htm 
 
EFSA-Q-2010-00071  
EFSA Journal 2013;11(4):3170 [13 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/317
0.htm 
 
Already QPS 
FEEDAP Streptomyces albus Production of 
salinomycin 
sodium 
EFSA-Q-2003-009 
The EFSA Journal (2008) 912, 1-13 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783414.htm 
 
EFSA-Q-2012-00994 
Streptomyces spp. produce antibiotics, are 
therefore inappropriate for QPS (EFSA opinion 
2008) 
FEEDAP Streptomyces aureofaciens Production of 
polyether 
monocarboxylic 
acid 
EFSA-Q-2003-046 
The EFSA Journal (2004), 90, 1-44 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783396.htm 
Streptomyces spp. produce antibiotics, are 
therefore inappropriate for QPS (EFSA opinion 
2008) 
FEEDAP Streptomyces cinnamonensis Production of 
monensin 
sodium 
EFSA-Q-2005-024 
The EFSA Journal (2004), 42, 1-61 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783743.htm 
 
EFSA-Q-2012-00906 
EFSA-Q-2012-00791 
Streptomyces spp. produce antibiotics, are 
therefore inappropriate for QPS (EFSA opinion 
2008) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
Pesticides Now unspecified Streptomyces 
species : ‘Streptomyces strain K 61’ 
Formerly : Streptomyces griseoviridis 
 
 
Plant protection 
product 
EFSA-Q-2009-00134  
EFSA-Q-2009-00295  
EFSA Journal 2013;11(1):3061. [40 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/3061.htm 
 
Streptomyces spp. produce antibiotics, are 
therefore inappropriate for QPS (EFSA opinion, 
2008) 
FEEDAP Streptomyces lasaliensis Production of 
lasalocid sodium 
EFSA-Q-2004-076 
The EFSA Journal (2004) 77, 1-45 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783432.htm 
Streptomyces spp. produce antibiotics, are 
therefore inappropriate for QPS (EFSA opinion, 
2008) 
Pesticides Streptomyces lydicus 
strain WYEC 108 (ATCC 55445) 
Plant protection 
product 
EFSA-Q-2012-00775  Streptomyces spp. produce antibiotics, are 
therefore inappropriate for QPS (EFSA opinion, 
2008).  
 Yeasts    
Pesticides  Aureobasidium pullulans strains 
DSM 14940 and DSM 14941 
Plant Protection 
Product 
EFSA-Q-2010-01499  
EFSA Journal 2011;9(11):2435  
www.efsa.europa.eu/en/efsajournal/pub/2435.htm 
 
EFSA-Q-2011-01200  
EFSA Journal 11(4): 3183 
www.efsa.europa.eu/en/efsajournal/pub/3183.htm 
Body of knowledge insufficient (QPS 2009 
update) 
FEEDAP Candida glabrata Feed additive  Unsuitable for QPS (see EFSA opinion 2007, 
Appendix C) 
FEEDAP Candida guilliermondi Fermentation 
product 
EFSA-Q-2003-082 
The EFSA Journal (2004) 68, 1-12 
www.efsa.europa.eu/en/efsajournal/pub/68.htm 
Unsuitable for QPS (see EFSA opinion 2007, 
Appendix C) 
Pesticides Candida oleophila strain O Plant protection 
product 
EFSA-Q-2009-00338  
EFSA Journal 2012;10(11):2944. [27 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2944.htm 
 
Body of knowledge insufficient, therefore not 
appropriate for QPS 
(EFSA opinion, 2008) 
FEEDAP Hansenula polymorpha = Pichia 
angusta 
Production of 
enzymes 
EFSA-Q-2005-030 
The EFSA Journal (2006) 333, 1-27 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620769671.htm 
Already QPS status applies only when species is 
used for production purposes (EFSA opinion, 
2008, 2010) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
2148/2004/EC Kluyveromyces marxianus var. 
lactisK1 
Feed additive  Already QPS 
Reg(EC)773/2
006 
Corrigendum 
CS 
Kluyveromyces marxianus-fragilis Feed additive  Already QPS 
FEEDAP Astaxanthin rich Phaffia rhodozyma 
= Xanthophyllomyces dendrorhous 
Production of 
astaxanthin 
EFSA-Q-2004-148 
The EFSA Journal (2004) 43, 1-4 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783707.htm 
 
EFSA-Q-2003-112 
The EFSA Journal (2004) 43, 1-4 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783707.htm 
Phaffia rhodozyma was assessed not appropriate 
for QPS (EFSA opinion 2008) because of 
insufficient body of knowledge. Later 
recommended for the QPS list (EFSA, 2011) as 
it is the imperfect form of Xanthophyllomyces 
dendrorhous according to the 2011 revision of 
the yeast taxonomy.  
FEEDAP Komagaella pastoris = 
Pichia pastoris 
Production of 
enzyme 
EFSA-Q_2006-025 (GMM) 
www.efsa.europa.eu/en/efsajournal/pub/627.htm 
and related opinions: 
EFSA-Q-2009-00804: 
www.efsa.europa.eu/en/efsajournal/pub/1550.htm 
 
EFSA-Q-2011-00148 
www.efsa.europa.eu/en/efsajournal/pub/2533.htm 
 
Other applications: 
EFSA-Q-2010-00152 (GMM) 
EFSA Journal 2011;9(11):2414 [2 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2414.htm 
EFSA-Q-2013-00022 (GMM) 
 
FEEDAP Saccharomyces cerevisiae Organic 
selenium source 
EFSA-Q-2005-071 
www.efsa.europa.eu/en/efsajournal/pub/348.htm 
 
EFSA-Q-2005-117  
 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
The EFSA Journal (2006) 348, 1-40  
www.efsa.europa.eu/en/efsajournal/pub/430.htm 
 
EFSA-Q-2008-381  
The EFSA Journal (2009) 992, 1-24  
www.efsa.europa.eu/en/efsajournal/pub/992.htm 
 
EFSA-Q-2009-00524  
EFSA Journal 2011;9(6):2279 
www.efsa.europa.eu/en/efsajournal/pub/2279.htm   
 
EFSA-Q-2009-00752 
EFSA Journal 2011;9(4):2110 
www.efsa.europa.eu/en/efsajournal/pub/2110.htm  
 
EFSA-Q-2010-01029  
EFSA Journal 2012;10(7):2778 [17 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/277
8.htm 
FEEDAP Saccharomyces cerevisiae Production of 
enzyme 
EFSA-Q-2005-224 (withdraw) 
 
EFSA-Q-2009-00534 (GMM) 
EFSA Journal 2011;9(12):2451 [19 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2451.htm 
 
and related application: 
EFSA-Q-2012-00909 
EFSA Journal 2013;11(7):3286 [8 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/328
6.htm 
 
 
 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Saccharomyces cerevisiae Feed additive EFSA-Q-2005-025 
The EFSA Journal (2006) 384, 1-9 
www.efsa.europa.eu/en/efsajournal/pub/384.htm 
 
EFSA-Q-2005-234  
The EFSA Journal (2006) 385, 1-9 
www.efsa.europa.eu/en/scdocs/scdoc/385.htm 
 
EFSA-Q-2005-149 
The EFSA Journal (2006) 321, 1-8 
www.efsa.europa.eu/en/scdocs/scdoc/321.htm 
 
EFSA-Q-2005-176 
www.efsa.europa.eu/en/efsajournal/pub/370.htm 
 
EFSA-Q-2006-003 
www.efsa.europa.eu/en/efsajournal/pub/379.htm 
 
EFSA-Q-2006-067 
www.efsa.europa.eu/en/efsajournal/pub/459.htm 
 
EFSA-Q-2007-104 
www.efsa.europa.eu/en/efsajournal/pub/585.htm 
EFSA-Q-2007-139 
The EFSA Journal (2008) 772, 1-11  
www.efsa.europa.eu/en/scdocs/scdoc/772.htm 
 
EFSA-Q-2007-165 
EFSA Journal 2009;7(10):1353 
www.efsa.europa.eu/en/scdocs/scdoc/1353.htm 
 
EFSA-Q-2008-009 
The EFSA Journal (2009) 991, 1-14 
Already QPS (EFSA Opinions 2007, 2008, 
2009, 2010, 2011, 2012, 2013). 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
www.efsa.europa.eu/en/scdocs/scdoc/991.htm 
 
EFSA-Q-2008-010  
The EFSA Journal (2008) 837, 1-10 
www.efsa.europa.eu/en/scdocs/scdoc/837.htm 
 
EFSA-Q-2008-302  
The EFSA Journal (2009) 970, 1-9 
www.efsa.europa.eu/en/scdocs/scdoc/970.htm 
 
EFSA-Q-2008-472  
The EFSA Journal (2009) 1040, 1-7 
www.efsa.europa.eu/en/scdocs/scdoc/1040.htm 
 
EFSA-Q-2009-00720  
EFSA Journal 2010;8(10):1864 
www.efsa.europa.eu/en/scdocs/scdoc/1864.htm 
 
EFSA-Q-2009-00753  
EFSA Journal 2010;8(7):1659 
www.efsa.europa.eu/en/scdocs/scdoc/1662.htm 
 
EFSA-Q-2009-00818 
EFSA Journal 2011;9(11):2439 
www.efsa.europa.eu/en/efsajournal/pub/2439.htm  
 
EFSA-Q-2009-00824 
EFSA Journal 2010;8(7):1662 
www.efsa.europa.eu/en/scdocs/scdoc/1662.htm 
 
EFSA-Q-2010-00936  
EFSA Journal 2012;10(1):2531  
www.efsa.europa.eu/en/efsajournal/pub/2531.htm 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
 
EFSA-Q-2010-00938  
 
EFSA-Q-2010-00992  
EFSA Journal 2011;9(5):2173 [10 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2173.htm 
 
EFSA-Q-2011-00390  
EFSA Journal 2013;11(10):3362 [13 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/336
2.htm 
GMO Saccharomyces cerevisiae Dried killed 
biomass for feed 
EFSA-Q-2007-156b (withdrawn) 
EFSA-Q-2009-00866 (withdrawn) 
 
FEEDAP Schizosaccharomyces pombe Production of 
enzymes 
EFSA-Q-2005-063 
The EFSA Journal (2006) 350, 1-14 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620769568.htm 
and related questions: 
EFSA-Q-2005-080 
The EFSA Journal (2006) 404, 1-20 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620782208.htm 
 
EFSA-Q-2008-272 
The EFSA Journal (2006) 350, 1-14 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620769568.htm 
 
EFSA-Q-2011-00835 
EFSA Journal 2012;10(3):2619 [9 pp.].   
http://www.efsa.europa.eu/en/efsajournal/pub/261
9.htm  
Already QPS (EFSA Opinions 2007, 2008, 
2009, 2010, 2011, 2012, 2013). 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Trichosporon mycotoxinivorans Feed additive EFSA-Q-2010-01030 (withdrawn) 
 
 
Not recommended for the QPS list, assessed in 
the 2011 update (EFSA, 2011) 
 Filamentous fungi    
Pesticides Ampelomyces quisqualis 
strain Q10 
Plant protection 
product 
EFSA-Q-2008-489  
Review Report for the active substance 
Ampelomyces quisqualis, EU-SANCO, 
4205/VI/98-Final, October 2004 
Not recommended for the QPS list (EFSA, 
2011, 2012, 2013) 
FEEDAP Ashbya gossypii  
 
Production of 
vitamin B2 
EFSA-Q-2012-00953 Not recommended for the QPS list (EFSA, 
2011, 2012, 2013) 
FEEDAP Aspergillus aculeatus Production of 
Enzyme 
EFSA-Q-2008-432 
The EFSA Journal (2009) 1186, 1-17 
www.efsa.europa.eu/en/efsajournal/pub/1186.htm 
 
EFSA-Q-2011-00035 
EFSA Journal 2011;9(2):2010 [5 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2010.htm 
 
EFSA-Q-2010-01297  
EFSA-Q-2010-01295 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
FEEDAP Aspergillus niger Feed additive  Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Aspergillus niger Production of 
Enzyme 
EFSA-Q-2004-068 (GMM) 
The EFSA Journal (2005) 198, 1-8 
www.efsa.europa.eu/en/efsajournal/pub/198.htm 
 
and related opinions: 
EFSA-Q-2006-119 
The EFSA Journal (2007) 474, 1-11 
www.efsa.europa.eu/en/efsajournal/pub/474.htm 
EFSA-Q-2008-418 
The EFSA Journal (2009) 1155, 1-14 
www.efsa.europa.eu/en/efsajournal/pub/1155.htm 
EFSA-Q-2011-00147  
EFSA Journal 2012;10(2):2575 [10 pp.]  
http://www.efsa.europa.eu/en/efsajournal/pub/257
5.htm 
 
EFSA-Q-2005-116  
The EFSA Journal (2006) 369, 1-19 
www.efsa.europa.eu/en/efsajournal/doc/369.pdf  
and related opinions:  
EFSA-Q-2007-049 
The EFSA Journal (2007) 472, 1-4 
www.efsa.europa.eu/en/efsajournal/pub/472.htm 
EFSA-Q-2007-041 
The EFSA Journal (2007) 544, 1-10 
www.efsa.europa.eu/en/efsajournal/pub/544.htm 
EFSA-Q-2007-189 
The EFSA Journal (2007) 614, 1-5 
www.efsa.europa.eu/en/efsajournal/pub/614.htm 
 
 
 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 92 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
   EFSA-Q-2008-692 
www.efsa.europa.eu/en/efsajournal/pub/1184.htm 
EFSA-Q-2009-00603 
www.efsa.europa.eu/en/efsajournal/pub/1427.htm 
EFSA-Q-2009-00534  
www.efsa.europa.eu/en/efsajournal/pub/2451.htm 
 
and related application: 
EFSA-Q-2012-00909 
 
EFSA-Q-2009-00585  
EFSA Journal 2013;11(8):3322  
http://www.efsa.europa.eu/en/efsajournal/pub/332
2.htm 
 
EFSA-Q-2008-013  
The EFSA Journal (2008) 914, 1-19 
www.efsa.europa.eu/en/efsajournal/pub/914.htm 
 
and related Questions: 
EFSA-Q-2010-00937 
EFSA Journal 2011;9(5):2172 
www.efsa.europa.eu/en/efsajournal/pub/2172.htm 
EFSA-Q-2011-00061  
EFSA Journal 2013;11(7):3285 [10 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/328
5.htm 
EFSA-Q-2010-01519  
EFSA-Q-2012-00411  
 
 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 93 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Aspergillus niger Production of 
Enzyme 
EFSA-Q-2008-013  
The EFSA Journal (2008) 914, 1-19 
www.efsa.europa.eu/en/efsajournal/pub/914.htm 
 
and related Questions: 
EFSA-Q-2010-00937 
EFSA Journal 2011;9(5):2172 
www.efsa.europa.eu/en/efsajournal/pub/2172.htm 
 
EFSA-Q-2011-00061  
EFSA Journal 2013;11(7):3285 [10 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/328
5.htm 
 
EFSA-Q-2010-01519  
 
EFSA-Q-2012-00411 
 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
FIP Aspergillus niger 
strain NZYM-BR 
Production of 
enzyme 
EFSA-Q-2013-00686 
The food enzyme is an amyloglucosidase 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 94 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Aspergillus oryzae Production of 
enzymes 
EFSA-Q-2003-012 
www.efsa.europa.eu/en/efsajournal/pub/66.htm 
and related opinions: 
EFSA-Q-2004-070 
The EFSA Journal (2004), 88, 1-6 
www.efsa.europa.eu/en/efsajournal/pub/88.htm 
EFSA-Q-2006-060 
The EFSA Journal (2007) 519, 1-8 
www.efsa.europa.eu/en/efsajournal/pub/519.htm 
EFSA-Q-2007-132 
EFSA Journal 2010;8(10):1862 [27 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/186
2.htm 
www.efsa.europa.eu/en/efsajournal/pub/132.htm 
EFSA-Q-2009-00535 
EFSA Journal 2010;8(12):1915 [12 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/191
5.htm 
 
EFSA-Q-2007-133 
The EFSA Journal (2008) 871, 1-16 
www.efsa.europa.eu/en/efsajournal/pub/871.htm 
 
and related opinions: 
EFSA-Q-2008-430 
The EFSA Journal (2009) 1097, 1-20 
www.efsa.europa.eu/en/efsajournal/pub/1097.htm 
EFSA-Q-2009-00536 
EFSA Journal 2010; 8(6):1634  
www.efsa.europa.eu/en/efsajournal/pub/1634.htm 
 
 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 95 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
   EFSA-Q-2008-419  
EFSA Journal 2012;10(7):2790 [21 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/279
0.htm 
 
EFSA-Q-2010-00769  
EFSA Journal 2012;10(1):2527 [12 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/252
7.htm 
 
and related opinion: 
EFSA-Q-2011-01172  
EFSA Journal 2012;10(6):2730 [9 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/273
0.htm 
EFSA-Q-2010-01519  
www.efsa.europa.eu/en/efsajournal/pub/2527.htm 
 
FEEDAP Aspergillus oryzae Feed additive  EFSA-Q-2009-00525  
 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
FIP Aspergillus oryzae 
strain NZYM-FB 
Production of 
food enzyme 
EFSA-Q-2012-00897 
The food enzyme is a xylanase 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
FIP Aspergillus oryzae 
strain NZYM-LH 
 
Production of 
food enzyme 
EFSA-Q-2012-01009 
The food enzyme is a lipase 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
FIP Aspergillus oryzae 
strain NZYM-NA 
Production of 
food enzyme 
EFSA-Q-2012-01010 
The food enzyme is an-alpha amylase 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FIP Aspergillus oryzae 
strain NZYM-AL 
Production of 
food enzyme 
EFSA-Q-2013-00198 
The food enzyme is a lipase 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
FIP Aspergillus oryzae 
strain NZYM-FL 
 
Production of 
food enzyme 
EFSA-Q-2013-00197 
The food enzyme is a lipase 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
FIP Aspergillus oryzae 
strain NZYM-SP 
Production of 
enzyme 
EFSA-Q-2013-00587 
The food enzyme is an asparaginase 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
FIP Aspergillus oryzae 
strain NZYM-KP 
Production of 
enzyme 
EFSA-Q-2013-00687 
The food enzyme is a glucose oxidase 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
FIP Aspergillus oryzae 
strain NZYM-FA 
Production of 
enzyme 
EFSA-Q-2013-00789 
The food enzyme is a xylanase 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
Pesticides Beauveria bassiana 
(ATCC-74040 and GHA)  
Plant protection 
product 
EFSA-Q-2009-00125  
EFSA-Q-2009-00251 and -252 
EFSA Journal 2013;11(1):3031. [44 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/3031.htm 
 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2011, 2012, 2013) 
Pesticides Beauveria brongniartii Plant protection 
product 
EFSA-Q-2009-00017  
No dossier received, notification withdrawn. 
Mycelial fungi: already considered as not 
appropriate for QPS. Insufficient body of 
knowledge, potential oosporein formation 
(see EFSA, 2007, 2009, 2010, 2011, 2012, 
2013) 
 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 97 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
ACF  
(as mentioned 
in the register 
of questions) 
Blakeslea trispora Production of 
lycopene (food 
colorant) 
Production of b-
carotene (food 
colorant) 
EFSA-Q-2004-102 
The EFSA Journal (2005) 275, 1-17 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620764493.htm 
 
EFSA-Q-2007-001 
The EFSA Journal (2008) 674, 1-66 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178700117557.htm 
Can not be proposed for QPS status (see EFSA 
opinion 2007, Appendix D; EFSA, 2009, 2010, 
2011, 2012, 2013) 
FEEDAP Blakeslea trispora Production 
strain for beta-
carotene 
EFSA-Q-2009-00884  
EFSA Journal 2012;10(6):2737 [33 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/273
7.htm 
Can not be proposed for QPS status (see EFSA 
opinion 2007, Appendix D; EFSA, 2009, 2010, 
2011, 2012, 2013) 
NDA Blakeslea trispora Food ingredient EFSA-Q-2004-169 
The EFSA Journal (2005) 212, 1-29 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620765774.htm 
 
EFSA-Q-2008-697 
The EFSA Journal (2008) 893, 1-15 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1211902228574.htm 
Can not be proposed for QPS status (see EFSA 
opinion 2007, Appendix D; EFSA, 2009, 2010, 
2011, 2012, 2013) 
Pesticides Coniothyrium minitans Plant protection 
product 
EFSA-Q-2008-515  
Review report for the active substance 
Coniotyrium minitans, SANCO/1400/2001-final, 
July 2003 
 
The body of knowledge is insufficient. Potential 
acrosphelide formation (EFSA, 2009, 2010, 
2011, 2012, 2013) 
 
FEEDAP Duddingtonia flagrans 
Alternative name: 
Trichothecium flagrans 
Feed additive EFSA-Q-2004-115 
The EFSA Journal (2006) 334, 1-8 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783270.htm 
 
EFSA-Q-2005-051 (withdrawn) 
Insufficient body of knowledge (EFSA, 2009; 
2010, 2011, 2012, 2013) 
 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 98 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
Pesticides Gliocladium catenulatum  
= Clonostachys rosea forma 
catenulata  
strain J1446 
 
Plant protection 
product 
EFSA-Q-2008-559  
Review report for the active substance 
Gliocladium catenulatum, SANCO/10383/2004-
rev.4, October 2004 
 
No recommendation for QPS in 2009 (EFSA, 
2009). No new relevant information in the 2010; 
2013 updates. 
Pesticides Lecanicillium muscarium  
Formerly Verticillium lecanii 
strain Ve6 
 
Plant protection 
product 
EFSA-Q-2009-00130  
EFSA-Q-2009-00255  
EFSA Journal 2010; 8(1):1446. [45 
pp.] 
www.efsa.europa.eu/en/efsajournal/pub/1446.htm 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2011, 2012, 2013) 
Pesticides Metarhizium anisopliae var. 
Anisopliae formerly 
M. anisopliae 
Plant protection 
product 
EFSA-Q-2009-00131  
EFSA-Q-2009-00253  
EFSA Journal 2012;10(1):2498. [44 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2498.htm 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2011, 2012, 2013) 
Pesticides Paecilomyces fumosoroseus 
strain FE 9901 (ARSEF 4490)  
(current name: Isaria fumosorosea) 
Plant protection 
product 
EFSA-Q-2013-00352  
EFSA-Q-2009-00323  
EFSA Journal 2012;10(9):2869. [26 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2869.htm 
 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2013) 
Pesticides 
 
Paecilomyces fumosoroseus 
strain Apopka 97, PFR 97 or CG170, 
ATCC20874 
(current name: Isaria fumosorosea) 
 
Plant protection 
product 
EFSA-Q-2008-599  Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2013) 
Pesticides Paecilomyces lilacinus 
strain 251  
Plant protection 
product 
EFSA-Q-2008-600  
EFSA-Q-2010-01337 
EFSA Scientific Report (2007)103,1-35 
www.efsa.europa.eu/en/efsajournal/pub/103r.htm 
 
Mycelial fungi: already considered as not 
appropriate for QPS. Potential for production of 
peptaibols (see EFSA, 2007, 2009, 2010, 2011, 
2012, 2013) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Penicillium funiculosum Production of 
Enzyme 
EFSA-Q-2005-281  
The EFSA Journal (2007) 471, 1-29 
www.efsa.europa.eu/en/efsajournal/pub/471.htm 
 
EFSA-Q-2010-01287  
EFSA Journal 2013;11(7):3321 [26 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/332
1.htm  
 
EFSA-Q-2011-00881  
 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2011, 2012, 2013) 
Pesticides Phlebiopsis gigantea 
14 different strains 
 
Plant protection 
product 
EFSA-Q-2009-00132  
EFSA-Q-2009-00285  
EFSA Journal 2013;11(1):3033 
www.efsa.europa.eu/en/efsajournal/pub/3033.htm 
Mycelial fungi: already considered as not 
appropriate for QPS. Insufficient body of 
knowledge (see EFSA, 2007, 2009, 2010, 2011, 
2012, 2013) 
Pesticides Pseudozyma flocculosa 
strain ATCC 64874 
Plant protection 
product 
EFSA-Q-2009-00315  
 
 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010, 2011, 2012, 2013) 
Pesticides Trichoderma asperellum strain T-34 
 
 
Plant protection 
product 
EFSA-Q-2011-00899  
EFSA Journal 2012;10(5):2666. 37 pp. 
www.efsa.europa.eu/en/efsajournal/pub/2666.htm 
EFSA-Q-2013-00013 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2011, 2012, 2013) 
Pesticides Trichoderma asperellum 
strains ICC 012, T25 and TV1 
(formerly Trichoderma viride T25 
and TV1) 
Plant protection 
product 
EFSA-Q-2009-00136  
EFSA-Q-2009-00298 and 300 
EFSA Journal 11(1): 3036 
www.efsa.europa.eu/en/efsajournal/pub/3036.htm 
 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2011, 2012, 2013) 
Pesticides Trichoderma atroviride SC1 Plant protection 
product  
EFSA question number not yet attributed 
Dossier not yet provided to EFSA 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2011, 2012, 2013) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
Pesticides Trichoderma atroviride I-1237 
 
Plant protection 
product 
EFSA-Q-2011-00900  
EFSA Journal 2012;10(10):2706. [33 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2706.htm 
EFSA-Q-2013-00039 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2011, 2012, 2013) 
Pesticides Trichoderma atroviride IMI 206040 
and T11 
 
Plant protection 
product 
EFSA-Q-2009-00137  
 
EFSA-Q-2009-00297  
http://registerofquestions.efsa.europa.eu/roqFronte
nd/questionsListLoader?unit=PRAS 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2011, 2012, 2013) 
FEEDAP Trichoderma citrinoviride Production of 
enzyme 
EFSA-Q-2010-00036  
EFSA Journal 2013;11(2):3105 
www.efsa.europa.eu/en/efsajournal/pub/3105.htm 
This was submitted as Trichoderma 
longibrachiatum but the assessment revealed 
that should be classified differently. 
 
New assessment for QPS 2013 update 
Pesticides Trichoderma gamsii  
strain ICC 080 
(formerly Trichoderma viride 
ICC080) 
Plant protection 
product 
EFSA-Q-2009-00138  
EFSA-Q-2012-00424 
EFSA Journal 2013;11(1):3062 
www.efsa.europa.eu/en/efsajournal/pub/3062.htm  
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2011, 2012, 2013) 
Pesticides Trichoderma harzianum Rifai 
(strains T22 and ITEM 908) 
 
Plant protection 
product 
EFSA-Q-2009-00139  
EFSA-Q-2009-00298  
Conclusion on the peer review: 
EFSA Journal 2013; 11(1):3055 
www.efsa.europa.eu/en/efsajournal/pub/3055.htm 
 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2011, 2012, 2013) 
FEEDAP Trichoderma koningii Production of 
enzyme 
EFSA-Q-2008-288 
EFSA Journal 2012;10(7):2843 [13 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/2843.htm  
 
This was submitted as Trichoderma 
longibrachiatum but the assessment revealed 
that should be classified as koningii. 
 
New assessment for QPS 2013 update 
FEEDAP Trichoderma longibrachiatum   Feed additive  Ineligible for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
QPS 2013 update  
 
EFSA Journal 2013;11(11):3449 101 
EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Trichoderma longibrachiatum Production of 
Enzyme 
EFSA-Q-2005-276 
The EFSA Journal (2006) 405, 1-10 
www.efsa.europa.eu/en/efsajournal/pub/405.htm 
 
and related opinion: 
EFSA-Q-2006-320 
The EFSA Journal (2007) 520, 1-8 
www.efsa.europa.eu/en/efsajournal/pub/520.htm 
EFSA-Q-2010-01532 
 
EFSA-Q-2008-288  
EFSA Journal 2012;10(7):2843 [13 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/284
3.htm 
EFSA-Q-2010-00036  
EFSA Journal 2013;11(2):3105 [23 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/310
5.htm 
EFSA-Q-2010-01025  
EFSA Journal 2013;11(7):3207 [18 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/320
7.htm 
EFSA-Q-2010-01295  
EFSA-Q-2010-01297  
EFSA-Q-2012-00411 
Ineligible for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
Pesticides Trichoderma polysporum 
strain IMI 206039 
 
 
Plant protection 
product 
EFSA-Q-2009-00140  
EFSA-Q-2009-00299  
EFSA Journal 2013;11(1):3035 
www.efsa.europa.eu/en/efsajournal/pub/3035.htm 
 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009, 2010, 2011, 2012, 2013) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Trichoderma reesei Production of 
enzyme 
EFSA-Q-2006-137  
The EFSA Journal (2007) 548, 1-18 
www.efsa.europa.eu/en/efsajournal/pub/548.htm 
 
and related opinions: 
EFSA-Q-2007-0020 
The EFSA Journal (2009) 1156, 1-25 
www.efsa.europa.eu/en/efsajournal/pub/1156.htm 
 
EFSA-Q-2007-109 
The EFSA Journal (2007) 586, 1-12 
www.efsa.europa.eu/en/efsajournal/pub/586.htm 
 
EFSA-Q-2007-112 
The EFSA Journal (2009) 1154, 1-11  
www.efsa.europa.eu/en/efsajournal/pub/1154.htm 
 
EFSA-Q-2007-185  
EFSA Journal 2012;10(11):2930 [2 pp.].  
http://www.efsa.europa.eu/en/efsajournal/pub/293
0.htm  
EFSA-Q-2009-00470 
EFSA Journal 2011;9(1):1949 [12 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/1949.htm 
 
EFSA-Q-2010-00141 
EFSA Journal 2010;8(12):1916 [22 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/1916.htm 
EFSA-Q-2009-00802 
EFSA Journal 2011;9(2):2008 
www.efsa.europa.eu/en/efsajournal/pub/2008.htm 
 
Ineligible for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
   EFSA-Q-2011-01171  
EFSA Journal 2012;10(6):2739 [11 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/273
9.htm  
 
EFSA-Q-2007-120  
The EFSA Journal (2008) 712, 1-19 
www.efsa.europa.eu/en/efsajournal/pub/712.htm 
 
and related question: 
EFSA-Q-2010-00142  
EFSA Journal 2011;9(6):2277 
www.efsa.europa.eu/en/efsajournal/pub/2277.htm 
 
EFSA-Q-2012-00065  
EFSA-Q-2012-00693 and EFSA-Q-2012-00905 
 
 
QPS 2013 update  
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EFSA 
Panel/Unit 
Microorganism species/strain  
 
Intended use Additional information provided by the EFSA 
Scientific Unit (see also EFSA register of 
questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
FEEDAP Trichoderma reesei Production of 
enzyme 
EFSA-Q-2008-308 
The EFSA Journal (2009) 1094, 1-17 
www.efsa.europa.eu/en/efsajournal/pub/1094.htm 
 
and related questions: 
EFSA-Q-2010-00018  
FSA Journal 2011;9(6):2278 [11 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/227
8.htm 
 
EFSA-Q-2008-432 
The EFSA Journal (2009) 1186, 1-17 
www.efsa.europa.eu/en/efsajournal/pub/1186.htm 
 
EFSA-Q-2008-748  
EFSA Journal 2009;7(11):1380 [27 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/1380.htm 
 
and related opinon: 
EFSA-Q-2010-0069 
EFSA Journal 2010; 8(3):1553 [4 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/1553.htm 
 
EFSA-Q-2010-00141 
EFSA Journal 2010;8(12):1916 [22 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/1916.htm 
 
EFSA-Q-2011-00112 
EFSA Journal 2011;9(3):2111 [5 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2111.htm 
 
Ineligible for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009, 2010, 2011, 
2012, 2013) 
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questions:  
http://registerofquestions.efsa.europa.eu/roqFr
ontend/questionsList.jsf ) 
Comments 
   EFSA-Q-2010-00700 
EFSA Journal 2010;8(12):1919 [10 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/1919.htm 
 
EFSA-Q_2011-00035 
EFSA Journal 2011;9(2):2010 [5 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2010.htm 
 
EFSA-Q-2011-00804  
EFSA Journal 2012;10(6):2728 [10 pp.]. 
http://www.efsa.europa.eu/en/efsajournal/pub/272
8.htm 
 
EFSA-Q-2012-00668 
EFSA Journal 2013;11(4):3172 [9 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/317
2.htm 
 
EFSA-Q-2012-00727 
EFSA Journal 2013;11(4):3171 [10 pp.] 
http://www.efsa.europa.eu/en/efsajournal/pub/317
1.htm 
 
EFSA-Q-2012-00085  
 
 
FEEDAP  Trichoderma viride Production of 
enzyme 
EFSA-Q-2010-01295  
EFSA-Q-2010-01297  
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007, 2009, 
2010, 2011, 2012, 2013) 
Pesticides Verticillium albo-atrum  
formerly Verticillium dahliae  
Plant protection 
product 
EFSA-Q-2009-00141  
EFSA-Q-2009-00303  
EFSA Journal 11(1): 3059 
www.efsa.europa.eu/en/efsajournal/pub/3059.htm 
Mycelial fungi: already considered as not 
appropriate for QPS. Potential production of 
alboatrin (see EFSA, 2007, 2009, 2010, 2011, 
2012, 2013) 
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 Oomycetes    
Pesticides Pythium oligandrum M1 
 
Plant protection 
product 
EFSA-Q-2009-00133  
EFSA-Q-2009-00287  
EFSA Journal 2013;11(1):3034. [31 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/3034.htm 
 
Mycelial fungi: already considered as not 
appropriate for QPS. Insufficient body of 
knowledge (see EFSA, 2007, 2009, 2010, 2011, 
2012, 2013) 
 Algae    
FEEDAP Haematococcus pluvialis Production of 
astaxanthin 
 No body of knowledge except for this strain. 
Therefore not considered for QPS 
(EFSA opinion 2008) 
 Bacteriophages    
FEEDAP Clostridium sporogenes phage Feed additive  QPS 2009, 2010 updates, no recommendation to 
the QPS list because phages are subject to a 
case-by-case assesment 
FEEDAP Clostridium tyrobutyricum phage Feed additive  QPS 2009, 2010 updates, no recommendation to 
the QPS list because phages are subject to a 
case-by-case assesment 
BIOHAZ Listeria moncytogenes phage Food surface 
decontamination 
EFSA-Q-2011-00959  
EFSA Journal 2012,10(3):2615. [43pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/2615.htm 
Phages were already assessed in QPS 2009, 
2010 updates and they are subject to a case-by-
case assessment 
 Viruses    
Pesticides Adoxophyes orana Granulovirus 
strain BV-0001 
Plant protection 
product 
EFSA-Q-2009-00324  
EFSA Journal 2012;10(4):2654. [32pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2654.htm 
EFSA-Q-2012-00894  
QPS 2009, 2010, 2011, 2012, 2013 updates 
recommended for the QPS list 
Pesticides Cydia pomonella granulovirus 
Mexican isolate 
Plant protection 
product 
EFSA-Q-2009-00126  
EFSA-Q-2009-00254  
EFSA Journal 2012;10(4):2655. [40 pp.] 
www.efsa.europa.eu/it/efsajournal/pub/2655.htm 
 
QPS 2009, 2010, 2011, 2012, 2013 updates 
recommended for the QPS list 
Pesticides Pepino Mosaic Virus Plant protection 
product 
EFSA question number not yet attributed 
Dossier not yet provided to EFSA 
New assessment for QPS 2013 update 
QPS 2013 update  
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Pesticides Helicoverpa armigera 
nucleopolyhedrovirus 
Plant protection 
product 
EFSA-Q-2009-00341  
EFSA Journal 2012;10(9):2865 [31 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2865.htm 
EFSA-Q-2013-00348 
QPS 2009, 2010, 2011, 2012, 2013 updates 
recommended for the QPS list 
Pesticides Spodoptera exigua nuclear 
polyhedrosis virus 
(current name: 
nucleopolyhedrovirus) 
Plant protection 
product 
EFSA-Q-2008-630  
Review Report for the active substance 
Spodoptera exigua nuclear polyhedrosis virus, 
SANCO/T14/2007-rev.final, March 2007 
QPS 2009, 2010, 2011, 2012, 2013 updates 
recommended for the QPS list 
Pesticides Spodoptera littoralis 
nucleopolyhedrovirus 
Plant protection 
product 
EFSA-Q-2009-00507  
EFSA Journal 2012;10(9):2864 [33 pp.] 
www.efsa.europa.eu/en/efsajournal/pub/2864.htm 
EFSA-Q-2013-00347 
QPS 2009, 2010, 2011, 2012, 2013 updates 
recommended for the QPS list 
Pesticides Zucchini yellow mosaic virus, weak 
strain 
Plant protection 
product 
EFSA-Q-2009-00346  
EFSA Journal 2012;10(6):2754. 
www.efsa.europa.eu/en/efsajournal/pub/2754.htm 
EFSA-Q-2013-00012  
QPS 2009, 2010, 2011, 2012, 2013 updates 
recommended for the QPS list 
Yeast Synonyms commonly used in the feed/food industry: 
 Wickerhamomyces anomalus: synonym Hansenula anomala, Pichia anomola, Saccharomyces anomalus 
 Pichia jadinii: anamorph Candida utilis; synonyms Hansenula jadinii, Torulopsis utilis 
 Saccharomyces cerevisiae synonym S. boulardii 
 Saccharomyces pastorianus: synonym of Saccharomyces carlsbergensis 
 Komagataella pastoris: synonym Pichia pastoris 
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